| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC16A13 SLC7A13 SLC16A9 SIDT1 GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 CYB561A3 XKR4 SLCO1B1 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 SLC16A6 TRPM3 KCNJ2 KCNJ4 SLC35B4 KCNJ10 KCNJ12 NPC1L1 SLC35A2 SCN7A SLC9B2 HPX KCNK10 HRH1 ATP11A GJB7 KCNJ18 SLC33A1 DISP1 SLC44A3 | 1.31e-18 | 1289 | 109 | 38 | GO:0005215 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.07e-18 | 145 | 109 | 17 | GO:0004713 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 SIDT1 GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 CYB561A3 SLCO1B1 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 SLC16A6 TRPM3 KCNJ2 KCNJ4 SLC35B4 KCNJ10 KCNJ12 SLC35A2 SCN7A SLC9B2 HPX KCNK10 HRH1 GJB7 KCNJ18 SLC33A1 DISP1 SLC44A3 | 3.76e-17 | 1180 | 109 | 35 | GO:0022857 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | FLT4 PDGFRB NTRK3 ROR1 DDR2 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.19e-15 | 65 | 109 | 12 | GO:0004714 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | FLT4 PDGFRB NTRK3 ROR1 DDR2 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.55e-14 | 85 | 109 | 12 | GO:0019199 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 7.60e-12 | 465 | 109 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | potassium channel activity | GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 KCNJ18 | 1.10e-10 | 128 | 109 | 11 | GO:0005267 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | GRIA2 GRIK1 GRIK2 KCNK4 SLC9A4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 KCNJ18 | 1.22e-10 | 167 | 109 | 12 | GO:0015079 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 4.63e-10 | 664 | 109 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR7D4 VN1R5 FLT4 DRD5 OR9A4 PDGFRB NTRK3 ROR1 DDR2 GRIA1 GRIA2 GRIK1 GRIK2 ADGRG4 PTH1R FZD8 FZD5 SCN7A MRGPRG HRH1 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK OR9A2 | 5.46e-10 | 1353 | 109 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 1.21e-09 | 627 | 109 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | protein kinase activity | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.06e-09 | 600 | 109 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 KCNJ18 | 5.50e-09 | 343 | 109 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 9.63e-09 | 793 | 109 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 2.62e-08 | 758 | 109 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | gated channel activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 KCNJ18 | 3.51e-08 | 334 | 109 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 5.27e-08 | 709 | 109 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 SLCO1B1 SLC16A6 SLC35B4 SLC33A1 | 7.02e-08 | 293 | 109 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.44e-08 | 140 | 109 | 9 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 8.71e-08 | 102 | 109 | 8 | GO:0005249 | |
| GeneOntologyMolecularFunction | kinase activity | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.61e-07 | 764 | 109 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | channel activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 GJB7 KCNJ18 | 1.70e-07 | 525 | 109 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 GJB7 KCNJ18 | 1.75e-07 | 526 | 109 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 SLCO1B1 SLC16A6 | 2.02e-07 | 207 | 109 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 KCNJ18 | 2.07e-07 | 459 | 109 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 SLCO1B1 SLC16A6 | 2.11e-07 | 208 | 109 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 3.93e-07 | 28 | 109 | 5 | GO:0005242 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.13e-06 | 193 | 109 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.34e-06 | 197 | 109 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 1.57e-06 | 5 | 109 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.86e-06 | 152 | 109 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.89e-06 | 17 | 109 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.26e-06 | 156 | 109 | 8 | GO:0019838 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.09e-06 | 938 | 109 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.13e-06 | 6 | 109 | 3 | GO:0015277 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.47e-06 | 171 | 109 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.02e-06 | 123 | 109 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 5.07e-06 | 46 | 109 | 5 | GO:0004715 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 SLCO1B3 SLCO1B1 SLC5A5 SLC9B1 SLC9A4 SLC35A2 SLC9B2 | 5.15e-06 | 296 | 109 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 5.45e-06 | 7 | 109 | 3 | GO:0005234 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.08e-06 | 182 | 109 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.67e-06 | 184 | 109 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 8.21e-06 | 24 | 109 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 9.36e-06 | 52 | 109 | 5 | GO:0042169 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC16A13 SLC7A13 SLC16A9 SLCO1B3 CYB561A3 SLCO1B1 SLC5A5 SLC9B1 SLC9A4 ATP8A1 SLC35A2 SLC9B2 | 1.16e-05 | 477 | 109 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.34e-05 | 27 | 109 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.81e-05 | 100 | 109 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.63e-05 | 75 | 109 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 8.41e-05 | 16 | 109 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.02e-04 | 17 | 109 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.22e-04 | 18 | 109 | 3 | GO:0015280 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.34e-04 | 90 | 109 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.76e-04 | 4 | 109 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.86e-04 | 52 | 109 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.66e-04 | 57 | 109 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.77e-04 | 105 | 109 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 2.92e-04 | 5 | 109 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | receptor signaling protein tyrosine kinase activator activity | 2.92e-04 | 5 | 109 | 2 | GO:0030298 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 3.03e-04 | 59 | 109 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.24e-04 | 60 | 109 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 4.21e-04 | 27 | 109 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 4.21e-04 | 27 | 109 | 3 | GO:0015271 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 4.21e-04 | 27 | 109 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor binding | 4.37e-04 | 6 | 109 | 2 | GO:0038085 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.40e-04 | 65 | 109 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.40e-04 | 65 | 109 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 6.09e-04 | 7 | 109 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 6.09e-04 | 7 | 109 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.26e-04 | 196 | 109 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 8.09e-04 | 8 | 109 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 8.37e-04 | 77 | 109 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 8.37e-04 | 34 | 109 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | SNARE binding | 9.02e-04 | 136 | 109 | 5 | GO:0000149 | |
| GeneOntologyMolecularFunction | antiporter activity | 9.63e-04 | 138 | 109 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.04e-03 | 9 | 109 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.04e-03 | 210 | 109 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.56e-03 | 42 | 109 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 1.57e-03 | 11 | 109 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.67e-03 | 43 | 109 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.67e-03 | 43 | 109 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.69e-03 | 93 | 109 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 2.57e-03 | 14 | 109 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 2.57e-03 | 14 | 109 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 2.57e-03 | 14 | 109 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.72e-03 | 51 | 109 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | protein domain specific binding | ABL1 GRIA1 GRIA2 GRIK2 FZD8 KCNJ4 SYNGR3 KCNJ12 SYP FGFR1 KCNJ18 KIT | 2.95e-03 | 875 | 109 | 12 | GO:0019904 |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.96e-03 | 15 | 109 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR7D4 VN1R5 DRD5 OR9A4 PDGFRB ADGRG4 PTH1R FZD8 FZD5 MRGPRG HRH1 OR9A2 | 3.20e-03 | 884 | 109 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | phosphatase binding | 3.29e-03 | 264 | 109 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 3.37e-03 | 16 | 109 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 3.37e-03 | 16 | 109 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | floppase activity | 3.37e-03 | 16 | 109 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 3.81e-03 | 17 | 109 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | cholesterol binding | 3.93e-03 | 58 | 109 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.12e-03 | 59 | 109 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 4.27e-03 | 18 | 109 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 4.75e-03 | 19 | 109 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 4.75e-03 | 19 | 109 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | myosin V binding | 5.26e-03 | 20 | 109 | 2 | GO:0031489 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | FLT4 ABL1 PDGFRB DDR2 JAK3 HPX FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.69e-10 | 327 | 108 | 15 | GO:0018108 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | FLT4 ABL1 PDGFRB DDR2 JAK3 HPX FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.84e-10 | 329 | 108 | 15 | GO:0018212 |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.43e-09 | 40 | 108 | 7 | GO:0048169 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.73e-09 | 228 | 108 | 12 | GO:0046777 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.19e-09 | 405 | 108 | 15 | GO:0033674 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 5.51e-09 | 490 | 108 | 16 | GO:0051347 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABL1 PDGFRB GRIA1 SLCO1B3 GRIA2 GRIK1 GRIK2 SLCO1B1 KCNK4 SLC5A5 JAK3 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 HPX KCNK10 HRH1 KCNJ18 | 6.98e-09 | 1374 | 108 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R TMEM203 KCNJ2 KCNJ10 SCN7A SLC9B2 HPX SYPL2 KDR FGFR1 FGFR3 FGFR4 | 2.44e-08 | 622 | 108 | 17 | GO:0098771 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 KCNJ10 SCN7A SLC9B2 HPX SYPL2 KDR FGFR1 FGFR3 | 2.56e-08 | 705 | 108 | 18 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 KCNJ10 SCN7A SLC9B2 HPX SYPL2 KDR FGFR1 FGFR3 | 3.31e-08 | 717 | 108 | 18 | GO:0050801 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ABL1 PDGFRB GRIA2 GRIK1 KCNK4 SLC5A5 JAK3 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 HPX KCNK10 HRH1 KCNJ18 | 1.16e-07 | 1157 | 108 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 2.13e-07 | 217 | 108 | 10 | GO:0051897 | |
| GeneOntologyBiologicalProcess | metal ion transport | ABL1 PDGFRB GRIK1 KCNK4 SLC5A5 JAK3 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 HPX KCNK10 HRH1 KCNJ18 | 2.16e-07 | 1000 | 108 | 20 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 2.65e-07 | 83 | 108 | 7 | GO:0048168 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABL1 GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 2.78e-07 | 1115 | 108 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 STAT3 STAT6 JAK3 FER KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.35e-07 | 747 | 108 | 17 | GO:0007169 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | FLT4 DRD5 ABL1 PDGFRB NTRK3 ROR1 DDR2 STAT3 PRR7 TBC1D20 FZD8 FZD5 MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.35e-07 | 1028 | 108 | 20 | GO:0043085 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | GRIK1 KCNK4 SLC9A4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 KCNJ18 | 3.95e-07 | 232 | 108 | 10 | GO:0071805 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ABL1 GRIA2 GRIK1 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 ATP8A1 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 4.00e-07 | 942 | 108 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 4.01e-07 | 293 | 108 | 11 | GO:0048167 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R STAT3 SLC9B1 SLC9A4 TMEM203 KCNJ2 KCNJ10 NPC1L1 SCN7A SLC9B2 HPX SYPL2 AACS KDR FGFR1 FGFR3 FGFR4 | 4.33e-07 | 1249 | 108 | 22 | GO:0048878 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 PTH1R STAT3 FZD8 FZD5 HPX KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 6.77e-07 | 879 | 108 | 18 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 PTH1R STAT3 FZD8 FZD5 HPX KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 6.77e-07 | 879 | 108 | 18 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 MASTL KDR FGFR1 FGFR3 FGFR4 LTK CERS1 KIT ALK | 1.03e-06 | 810 | 108 | 17 | GO:0051338 |
| GeneOntologyBiologicalProcess | potassium ion transport | GRIK1 KCNK4 SLC9A4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 KCNJ18 | 1.68e-06 | 272 | 108 | 10 | GO:0006813 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | FLT4 DRD5 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 KIT | 1.70e-06 | 571 | 108 | 14 | GO:0043410 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 2.88e-06 | 686 | 108 | 15 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 HPX KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 2.97e-06 | 780 | 108 | 16 | GO:0042327 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | FLT4 ABL1 DPY19L1 PDGFRB NTRK3 DDR2 JAK3 HPX FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.00e-06 | 976 | 108 | 18 | GO:0018193 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | FLT4 DRD5 ABL1 PDGFRB NTRK3 ROR1 DDR2 STAT3 PRR7 TBC1D20 FZD8 FZD5 SYNGR3 FER MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.07e-06 | 1430 | 108 | 22 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 4.84e-06 | 22 | 108 | 4 | GO:0048172 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 4.84e-06 | 22 | 108 | 4 | GO:0038083 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 4.84e-06 | 240 | 108 | 9 | GO:0070374 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 5.27e-06 | 382 | 108 | 11 | GO:0043491 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ABL1 GRIK1 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 5.86e-06 | 922 | 108 | 17 | GO:0098662 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 6.95e-06 | 51 | 108 | 5 | GO:1990573 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ABL1 NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 KCNJ2 KCNJ10 SCN7A KCNK10 KDR | 7.25e-06 | 559 | 108 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 KCNJ10 SYNGR1 HRH1 SYP KDR KIT | 9.44e-06 | 663 | 108 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 KCNJ10 SYNGR1 HRH1 SYP KDR KIT | 9.60e-06 | 664 | 108 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1.03e-05 | 334 | 108 | 10 | GO:0051896 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.14e-05 | 27 | 108 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 ITGB8 STAT3 STAT6 JAK3 FER KDR FGFR1 FGFR3 FGFR4 LTK TNFAIP6 KIT ALK | 1.17e-05 | 1186 | 108 | 19 | GO:0007167 |
| GeneOntologyBiologicalProcess | positive regulation of hepatic stellate cell activation | 1.63e-05 | 10 | 108 | 3 | GO:2000491 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.63e-05 | 10 | 108 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 SCN7A HPX SYPL2 | 1.86e-05 | 611 | 108 | 13 | GO:0030003 |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.89e-05 | 105 | 108 | 6 | GO:0048708 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ABL1 GRIK1 KCNK4 SLC5A5 SLC9B1 SLC9A4 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 KCNK10 HRH1 KCNJ18 | 2.09e-05 | 1017 | 108 | 17 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | FLT4 DRD5 ABL1 PDGFRB NTRK3 ROR1 DDR2 GRIK2 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 KIT | 2.24e-05 | 815 | 108 | 15 | GO:0043408 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 SCN7A HPX SYPL2 | 2.24e-05 | 622 | 108 | 13 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 3.80e-05 | 389 | 108 | 10 | GO:0055074 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 PTH1R STAT3 FZD8 FZD5 HPX FER MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.31e-05 | 1421 | 108 | 20 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 PTH1R STAT3 FZD8 FZD5 HPX FER MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.40e-05 | 1423 | 108 | 20 | GO:0051174 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 SCN7A SLC9B2 HPX SYPL2 AACS | 4.51e-05 | 866 | 108 | 15 | GO:0055082 |
| GeneOntologyBiologicalProcess | synaptic signaling | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 PRR7 KCNJ10 SYNGR3 SYNGR1 HRH1 SYP KDR KIT | 4.75e-05 | 976 | 108 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of hepatic stellate cell activation | 4.87e-05 | 14 | 108 | 3 | GO:2000489 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 5.02e-05 | 249 | 108 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 5.62e-05 | 40 | 108 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | response to growth factor | FLT4 ABL1 PDGFRB NTRK3 DDR2 GRIA1 GRIA2 ITGB8 STAT3 FER KDR FGFR1 FGFR3 FGFR4 TNFAIP6 | 5.62e-05 | 883 | 108 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 6.05e-05 | 129 | 108 | 6 | GO:0043406 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | ABL1 ITGB8 TSPAN2 STAT3 PRR7 STAT6 FZD8 JAK3 FZD5 SLC9B2 FES FGFR3 TNFAIP6 KIT | 6.39e-05 | 789 | 108 | 14 | GO:0002521 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC16A13 SLC7A13 SLC16A9 SLCO1B3 GRIK1 SLCO1B1 SLC16A6 SLC35B4 KCNJ10 SLC35A2 SLC33A1 | 8.22e-05 | 515 | 108 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 8.31e-05 | 198 | 108 | 7 | GO:0007259 | |
| GeneOntologyBiologicalProcess | MAPK cascade | FLT4 DRD5 ABL1 PDGFRB NTRK3 ROR1 DDR2 GRIK2 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 KIT | 1.00e-04 | 930 | 108 | 15 | GO:0000165 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 KCNJ10 SYNGR3 SYNGR1 HRH1 SYP KDR KIT | 1.02e-04 | 931 | 108 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 KCNJ10 SYNGR3 SYNGR1 HRH1 SYP KDR KIT | 1.02e-04 | 931 | 108 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.03e-04 | 142 | 108 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.03e-04 | 142 | 108 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | hepatic stellate cell activation | 1.08e-04 | 18 | 108 | 3 | GO:0035733 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 1.11e-04 | 90 | 108 | 5 | GO:0007260 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR STAT3 KCNJ10 SYNGR3 SYNGR1 HRH1 SYP KDR KIT | 1.12e-04 | 939 | 108 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FLT4 ABL1 PDGFRB NTRK3 DDR2 GRIA1 GRIA2 ITGB8 STAT3 KDR FGFR1 FGFR3 FGFR4 TNFAIP6 | 1.40e-04 | 850 | 108 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.43e-04 | 216 | 108 | 7 | GO:0097696 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 1.62e-04 | 4 | 108 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | response to stem cell factor | 1.62e-04 | 4 | 108 | 2 | GO:0036215 | |
| GeneOntologyBiologicalProcess | cellular response to stem cell factor stimulus | 1.62e-04 | 4 | 108 | 2 | GO:0036216 | |
| GeneOntologyBiologicalProcess | positive regulation of parathyroid hormone secretion | 1.62e-04 | 4 | 108 | 2 | GO:2000830 | |
| GeneOntologyBiologicalProcess | Kit signaling pathway | 1.62e-04 | 4 | 108 | 2 | GO:0038109 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | DRD5 ABL1 PDGFRB DDR2 GRIA1 GRIA2 KCNK4 STAT3 STAT6 FANCC SLC5A5 JAK3 SLC9B2 AACS FER FES LTK CERS1 ALK | 1.76e-04 | 1450 | 108 | 19 | GO:1901701 |
| GeneOntologyBiologicalProcess | cellular homeostasis | DRD5 ABL1 GRIA1 GRIK2 CYB561A3 PTH1R SLC9B1 SLC9A4 TMEM203 KCNJ2 SCN7A SLC9B2 HPX SYPL2 AACS | 1.80e-04 | 981 | 108 | 15 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 1.93e-04 | 385 | 108 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | FLT4 ABL1 PDGFRB NTRK3 ROR1 DDR2 FZD8 FZD5 HPX FER KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 2.09e-04 | 1226 | 108 | 17 | GO:0042325 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 2.59e-04 | 59 | 108 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | fibroblast activation | 2.61e-04 | 24 | 108 | 3 | GO:0072537 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | FLT4 ABL1 PDGFRB NTRK3 DDR2 STAT3 ATP8A1 FER KDR FGFR1 TNFAIP6 KIT | 2.69e-04 | 691 | 108 | 12 | GO:0030335 |
| GeneOntologyBiologicalProcess | regulation of parathyroid hormone secretion | 2.69e-04 | 5 | 108 | 2 | GO:2000828 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 3.32e-04 | 26 | 108 | 3 | GO:0060396 | |
| GeneOntologyBiologicalProcess | cellular response to reactive oxygen species | 3.51e-04 | 178 | 108 | 6 | GO:0034614 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 3.53e-04 | 418 | 108 | 9 | GO:0070371 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 3.73e-04 | 27 | 108 | 3 | GO:0071378 | |
| GeneOntologyBiologicalProcess | organ growth | 4.02e-04 | 256 | 108 | 7 | GO:0035265 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 4.02e-04 | 6 | 108 | 2 | GO:0090080 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | FLT4 ABL1 PDGFRB NTRK3 DDR2 FZD8 FZD5 HPX KDR FGFR1 FGFR3 KIT | 4.09e-04 | 724 | 108 | 12 | GO:0001934 |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | FLT4 ABL1 PDGFRB NTRK3 DDR2 STAT3 ATP8A1 FER KDR FGFR1 TNFAIP6 KIT | 4.14e-04 | 725 | 108 | 12 | GO:2000147 |
| GeneOntologyBiologicalProcess | central nervous system development | ABL1 NTRK3 ROR1 GRIA1 GRIK1 TSPAN2 STAT3 FANCC KCNA3 KCNJ10 SYNGR3 SYPL2 FGFR1 FGFR3 CERS1 ALK | 4.89e-04 | 1197 | 108 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | FLT4 ABL1 PDGFRB NTRK3 DDR2 STAT3 ATP8A1 FER KDR FGFR1 TNFAIP6 KIT | 5.09e-04 | 742 | 108 | 12 | GO:0040017 |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell proliferation | 5.11e-04 | 125 | 108 | 5 | GO:0001938 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 5.12e-04 | 350 | 108 | 8 | GO:0045860 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 5.33e-04 | 640 | 108 | 11 | GO:1903131 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 5.39e-04 | 193 | 108 | 6 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 5.54e-04 | 194 | 108 | 6 | GO:0043405 | |
| GeneOntologyCellularComponent | receptor complex | FLT4 PDGFRB NTRK3 ROR1 DDR2 GRIA1 GRIA2 GRIK1 GRIK2 ITGB8 PTH1R KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.40e-09 | 581 | 110 | 18 | GO:0043235 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TMEM249 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 KCNJ18 | 1.20e-08 | 378 | 110 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 ATP8A1 TMEM249 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 ATP11A KCNJ18 | 3.03e-08 | 550 | 110 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 3.69e-08 | 179 | 110 | 10 | GO:0099501 |
| GeneOntologyCellularComponent | synaptic vesicle membrane | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 3.69e-08 | 179 | 110 | 10 | GO:0030672 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 TMEM249 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 KCNJ18 | 6.45e-07 | 523 | 110 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transport vesicle membrane | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 3.43e-06 | 293 | 110 | 10 | GO:0030658 |
| GeneOntologyCellularComponent | synaptic vesicle | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 4.22e-06 | 300 | 110 | 10 | GO:0008021 |
| GeneOntologyCellularComponent | exocytic vesicle | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 7.45e-06 | 320 | 110 | 10 | GO:0070382 |
| GeneOntologyCellularComponent | potassium channel complex | 1.85e-05 | 104 | 110 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | transport vesicle | GRIA1 GRIA2 SYNPR ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP FGFR3 FGFR4 | 1.87e-05 | 519 | 110 | 12 | GO:0030133 |
| GeneOntologyCellularComponent | cation channel complex | 3.46e-05 | 235 | 110 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 5.59e-05 | 405 | 110 | 10 | GO:0045211 | |
| GeneOntologyCellularComponent | presynapse | ROR1 GRIA1 GRIA2 GRIK1 GRIK2 SYNPR KCNA3 ATP8A1 KCNJ10 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP | 6.23e-05 | 886 | 110 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 9.16e-05 | 45 | 110 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DRD5 NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 STAT3 PRR7 KCNA3 ATP8A1 KCNJ2 FZD5 KCNJ4 FGFR1 | 9.84e-05 | 817 | 110 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | DRD5 ABL1 TMEM50A GRIA1 GRIA2 GRIK1 GRIK2 KCNJ2 FZD5 KCNJ4 KCNJ10 KCNJ12 KDR KCNJ18 ALK | 1.06e-04 | 929 | 110 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.39e-04 | 50 | 110 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | perisynaptic space | 1.64e-04 | 4 | 110 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.84e-04 | 157 | 110 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC7A13 PDGFRB TMEM114 DDR2 PTH1R SLC9A4 UPK1B KCNJ10 NPC1L1 SLC9B2 | 2.52e-04 | 487 | 110 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | synaptic membrane | DRD5 NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 PRR7 KCNA3 KCNJ2 KCNJ4 SYP | 2.54e-04 | 583 | 110 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.93e-04 | 320 | 110 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.16e-04 | 112 | 110 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 4.06e-04 | 6 | 110 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | neuronal cell body | DRD5 ABL1 TMEM50A GRIA1 GRIA2 GRIK1 GRIK2 KCNJ2 FZD5 KCNJ4 KCNJ12 KDR KCNJ18 | 4.46e-04 | 835 | 110 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | sodium channel complex | 4.69e-04 | 29 | 110 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.72e-04 | 354 | 110 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | dendrite | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 PRR7 KCNJ2 FZD5 KCNJ4 KCNJ12 HRH1 KCNJ18 | 5.76e-04 | 858 | 110 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DRD5 ABL1 GRIA1 GRIA2 GRIK1 GRIK2 PRR7 KCNJ2 FZD5 KCNJ4 KCNJ12 HRH1 KCNJ18 | 5.88e-04 | 860 | 110 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.86e-04 | 201 | 110 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | secretory vesicle | GRIA1 PSMD1 GRIA2 SYNPR FZD8 SLC9A4 ATP8A1 SYNGR3 SYNGR2 SYNGR1 SLC9B2 SYPL2 SYP ATP11A TNFAIP6 KIT | 8.02e-04 | 1246 | 110 | 16 | GO:0099503 |
| GeneOntologyCellularComponent | axon terminus | 8.61e-04 | 210 | 110 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | GRIA1 GRIA2 GRIK1 GRIK2 ITGB8 FZD8 KCNA3 TMEM249 KCNJ2 KCNJ4 SCN7A GJB7 | 8.75e-04 | 785 | 110 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | basal part of cell | 8.76e-04 | 378 | 110 | 8 | GO:0045178 | |
| GeneOntologyCellularComponent | postsynapse | DRD5 ABL1 NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 STAT3 PRR7 KCNA3 KCNJ2 KCNJ4 SYP FGFR1 | 9.08e-04 | 1018 | 110 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | apical part of cell | SLC7A13 PDGFRB TMEM114 DDR2 PTH1R SLC9A4 UPK1B KCNJ10 NPC1L1 SLC9B2 | 1.14e-03 | 592 | 110 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GRIA1 GRIA2 CYB561A3 SYNPR SLC9A4 ATP8A1 FZD5 KCNJ4 SYNGR3 SYNGR2 NPC1L1 SYNGR1 SLC9B2 SYPL2 SYP ATP11A | 1.33e-03 | 1307 | 110 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | neuron projection terminus | 1.47e-03 | 233 | 110 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | vesicle membrane | GRIA1 GRIA2 CYB561A3 SYNPR SLC9A4 ATP8A1 FZD5 KCNJ4 SYNGR3 SYNGR2 NPC1L1 SYNGR1 SLC9B2 SYPL2 SYP ATP11A | 1.53e-03 | 1325 | 110 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | sperm principal piece | 1.60e-03 | 44 | 110 | 3 | GO:0097228 | |
| GeneOntologyCellularComponent | terminal bouton | 1.66e-03 | 96 | 110 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.78e-03 | 523 | 110 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | anchoring junction | PDGFRB DDR2 GRIA1 ITGB8 KCNJ2 FZD5 FER FES KDR FGFR3 FGFR4 GJB7 KIT | 1.85e-03 | 976 | 110 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | somatodendritic compartment | DRD5 ABL1 TMEM50A GRIA1 GRIA2 GRIK1 GRIK2 PRR7 KCNJ2 FZD5 KCNJ4 KCNJ12 HRH1 KDR KCNJ18 | 1.93e-03 | 1228 | 110 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | glial cell projection | 1.94e-03 | 47 | 110 | 3 | GO:0097386 | |
| GeneOntologyCellularComponent | membrane protein complex | GRIA1 GRIA2 GRIK1 GRIK2 ITGB8 KCNK4 FZD8 KCNA3 TMEM249 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A KCNK10 GJB7 KCNJ18 | 2.10e-03 | 1498 | 110 | 17 | GO:0098796 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.40e-03 | 14 | 110 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | axon | DRD5 ABL1 NTRK3 ROR1 GRIA1 GRIA2 GRIK1 GRIK2 KCNA3 FZD5 SYP ALK | 2.54e-03 | 891 | 110 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic density | 2.66e-03 | 451 | 110 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.98e-03 | 185 | 110 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.48e-03 | 277 | 110 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | lysosome | PDGFRB SIDT1 PSMD1 CYB561A3 TMEM203 ATP8A1 SULT1C2 SYNGR1 SLC9B2 ATP11A FGFR3 | 3.64e-03 | 811 | 110 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | PDGFRB SIDT1 PSMD1 CYB561A3 TMEM203 ATP8A1 SULT1C2 SYNGR1 SLC9B2 ATP11A FGFR3 | 3.64e-03 | 811 | 110 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | asymmetric synapse | 3.73e-03 | 477 | 110 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.12e-03 | 503 | 110 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 7.42e-03 | 230 | 110 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPY19L1 GRIA1 TBC1D20 FADS1 TMEM203 SLC35B4 AGMO SLC35A2 ATP11A CERS1 FITM1 MOGAT3 SLC33A1 TMEM50B | 7.89e-03 | 1293 | 110 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | distal axon | 8.18e-03 | 435 | 110 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPY19L1 GRIA1 TBC1D20 FADS1 TMEM203 SLC35B4 AGMO SLC35A2 ATP11A CERS1 FITM1 MOGAT3 SLC33A1 TMEM50B | 8.20e-03 | 1299 | 110 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | T-tubule | 8.39e-03 | 79 | 110 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | vacuole | PDGFRB SIDT1 PSMD1 CYB561A3 TMEM203 ATP8A1 SULT1C2 SYNGR1 SLC9B2 ATP11A FGFR3 | 8.66e-03 | 913 | 110 | 11 | GO:0005773 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 9.14e-03 | 155 | 110 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | brush border membrane | 9.60e-03 | 83 | 110 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPY19L1 GRIA1 TBC1D20 FADS1 TMEM203 SLC35B4 AGMO SLC35A2 ATP11A CERS1 FITM1 MOGAT3 SLC33A1 TMEM50B | 9.79e-03 | 1327 | 110 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | neuron spine | 9.92e-03 | 247 | 110 | 5 | GO:0044309 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.08e-02 | 30 | 110 | 2 | GO:0032281 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.23e-02 | 91 | 110 | 3 | GO:0008076 | |
| HumanPheno | Hematological neoplasm | FLT4 ABL1 PDGFRB PTH1R NAGS STAT3 STAT6 FANCC TRPM3 KDR FGFR1 KIT DISP1 | 4.27e-06 | 424 | 37 | 13 | HP:0004377 |
| HumanPheno | Abnormality of thyroid physiology | PDGFRB GRIA1 STAT3 DNAH1 SLC5A5 KCNJ2 KCNJ10 SLC35A2 ATP11A FGFR1 KCNJ18 DISP1 | 2.62e-05 | 425 | 37 | 12 | HP:0002926 |
| HumanPheno | Bilirubinuria | 5.13e-05 | 2 | 37 | 2 | HP:0031811 | |
| HumanPheno | Anterior bulging of the globe | 1.39e-04 | 283 | 37 | 9 | HP:0000644 | |
| HumanPheno | Proptosis | 1.39e-04 | 283 | 37 | 9 | HP:0000520 | |
| HumanPheno | Neoplasm by anatomical site | FLT4 ABL1 PDGFRB DDR2 PTH1R NAGS STAT3 STAT6 FANCC TRPM3 KCNJ10 KDR FGFR1 FGFR3 KIT ALK DISP1 | 1.44e-04 | 959 | 37 | 17 | HP:0011793 |
| HumanPheno | Multiple unerupted teeth | 1.53e-04 | 3 | 37 | 2 | HP:0006283 | |
| HumanPheno | Abnormality of the supraorbital ridges | 1.60e-04 | 116 | 37 | 6 | HP:0100538 | |
| HumanPheno | Capillary hemangioma | 1.62e-04 | 39 | 37 | 4 | HP:0005306 | |
| HumanPheno | Short palm | 1.76e-04 | 118 | 37 | 6 | HP:0004279 | |
| HumanPheno | Myeloproliferative disorder | 1.85e-04 | 16 | 37 | 3 | HP:0005547 | |
| Domain | TyrKc | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 9.00e-22 | 88 | 107 | 17 | SM00219 |
| Domain | Tyr_kinase_cat_dom | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 9.00e-22 | 88 | 107 | 17 | IPR020635 |
| Domain | PROTEIN_KINASE_TYR | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 5.32e-21 | 97 | 107 | 17 | PS00109 |
| Domain | Tyr_kinase_AS | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 5.32e-21 | 97 | 107 | 17 | IPR008266 |
| Domain | Pkinase_Tyr | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 8.62e-19 | 129 | 107 | 17 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 2.81e-18 | 138 | 107 | 17 | IPR001245 |
| Domain | Prot_kinase_dom | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.31e-10 | 489 | 107 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.77e-10 | 493 | 107 | 18 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 9.86e-10 | 459 | 107 | 17 | PS00107 |
| Domain | Kinase-like_dom | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES MASTL KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.71e-09 | 542 | 107 | 18 | IPR011009 |
| Domain | Protein_kinase_ATP_BS | FLT4 ABL1 PDGFRB MATK NTRK3 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.28e-09 | 379 | 107 | 15 | IPR017441 |
| Domain | MARVEL | 8.24e-09 | 27 | 107 | 6 | PF01284 | |
| Domain | Marvel | 1.04e-08 | 28 | 107 | 6 | IPR008253 | |
| Domain | MARVEL | 1.04e-08 | 28 | 107 | 6 | PS51225 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 2.33e-08 | 16 | 107 | 5 | IPR013518 | |
| Domain | IRK | 2.33e-08 | 16 | 107 | 5 | PF01007 | |
| Domain | - | 2.33e-08 | 16 | 107 | 5 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 2.33e-08 | 16 | 107 | 5 | IPR016449 | |
| Domain | Tyr_kinase_rcpt_3_CS | 7.00e-08 | 8 | 107 | 4 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 7.00e-08 | 8 | 107 | 4 | PS00240 | |
| Domain | K_chnl_inward-rec_Kir_N | 1.83e-07 | 3 | 107 | 3 | IPR013673 | |
| Domain | IRK_N | 1.83e-07 | 3 | 107 | 3 | PF08466 | |
| Domain | Tyr_kinase_rcpt_2_CS | 3.26e-07 | 11 | 107 | 4 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 4.86e-07 | 12 | 107 | 4 | PS00239 | |
| Domain | FGF_rcpt_fam | 7.28e-07 | 4 | 107 | 3 | IPR016248 | |
| Domain | Synaptogyrin | 7.28e-07 | 4 | 107 | 3 | IPR016579 | |
| Domain | Synaptophysin/porin | 7.28e-07 | 4 | 107 | 3 | IPR001285 | |
| Domain | MFS_dom | SLC16A13 SLC16A9 SLCO1B3 UNC93A SLCO1B1 SLC16A6 MFSD13A SLC33A1 | 1.02e-06 | 134 | 107 | 8 | IPR020846 |
| Domain | Iontro_rcpt | 2.93e-06 | 18 | 107 | 4 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.93e-06 | 18 | 107 | 4 | PF10613 | |
| Domain | Iono_rcpt_met | 2.93e-06 | 18 | 107 | 4 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.93e-06 | 18 | 107 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.93e-06 | 18 | 107 | 4 | SM00918 | |
| Domain | Lig_chan | 2.93e-06 | 18 | 107 | 4 | PF00060 | |
| Domain | PBPe | 2.93e-06 | 18 | 107 | 4 | SM00079 | |
| Domain | SH2 | 3.26e-06 | 110 | 107 | 7 | SM00252 | |
| Domain | SH2 | 3.46e-06 | 111 | 107 | 7 | PS50001 | |
| Domain | SH2 | 3.67e-06 | 112 | 107 | 7 | IPR000980 | |
| Domain | - | 3.67e-06 | 112 | 107 | 7 | 3.30.505.10 | |
| Domain | Ig_I-set | 1.37e-05 | 190 | 107 | 8 | IPR013098 | |
| Domain | ig | 1.37e-05 | 190 | 107 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.37e-05 | 190 | 107 | 8 | IPR013151 | |
| Domain | I-set | 1.37e-05 | 190 | 107 | 8 | PF07679 | |
| Domain | SH2 | 2.50e-05 | 101 | 107 | 6 | PF00017 | |
| Domain | SYNAPTOP | 3.25e-05 | 2 | 107 | 2 | PS00604 | |
| Domain | Tyr-prot_kinase_Fes/Fps | 3.25e-05 | 2 | 107 | 2 | IPR016250 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 3.25e-05 | 2 | 107 | 2 | IPR003272 | |
| Domain | UPF0220 | 3.25e-05 | 2 | 107 | 2 | PF05255 | |
| Domain | UPF0220 | 3.25e-05 | 2 | 107 | 2 | IPR007919 | |
| Domain | ANF_lig-bd_rcpt | 5.81e-05 | 37 | 107 | 4 | IPR001828 | |
| Domain | ANF_receptor | 5.81e-05 | 37 | 107 | 4 | PF01094 | |
| Domain | IGc2 | 6.23e-05 | 235 | 107 | 8 | SM00408 | |
| Domain | Ig_sub2 | 6.23e-05 | 235 | 107 | 8 | IPR003598 | |
| Domain | Na_H_Exchanger | 6.36e-05 | 14 | 107 | 3 | PF00999 | |
| Domain | Cation/H_exchanger | 6.36e-05 | 14 | 107 | 3 | IPR006153 | |
| Domain | Peripla_BP_I | 7.18e-05 | 39 | 107 | 4 | IPR028082 | |
| Domain | Ig_E-set | 3.29e-04 | 104 | 107 | 5 | IPR014756 | |
| Domain | Frizzled_dom | 3.39e-04 | 24 | 107 | 3 | IPR020067 | |
| Domain | FZ | 3.39e-04 | 24 | 107 | 3 | PS50038 | |
| Domain | Fz | 3.39e-04 | 24 | 107 | 3 | PF01392 | |
| Domain | GPCR_2-like | 3.88e-04 | 60 | 107 | 4 | IPR017981 | |
| Domain | MFS | 3.92e-04 | 108 | 107 | 5 | PS50850 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.13e-04 | 61 | 107 | 4 | PS50261 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 4.80e-04 | 6 | 107 | 2 | IPR016243 | |
| Domain | STAT_TF_prot_interaction | 6.70e-04 | 7 | 107 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 6.70e-04 | 7 | 107 | 2 | IPR012345 | |
| Domain | STAT | 6.70e-04 | 7 | 107 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 6.70e-04 | 7 | 107 | 2 | IPR015988 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 6.70e-04 | 7 | 107 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.70e-04 | 7 | 107 | 2 | IPR013801 | |
| Domain | STAT_bind | 6.70e-04 | 7 | 107 | 2 | PF02864 | |
| Domain | STAT_int | 6.70e-04 | 7 | 107 | 2 | PF02865 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.70e-04 | 7 | 107 | 2 | PF01017 | |
| Domain | - | 6.70e-04 | 7 | 107 | 2 | 1.20.1050.20 | |
| Domain | IG | 7.05e-04 | 421 | 107 | 9 | SM00409 | |
| Domain | Ig_sub | 7.05e-04 | 421 | 107 | 9 | IPR003599 | |
| Domain | Tetraspanin | 8.03e-04 | 32 | 107 | 3 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 8.03e-04 | 32 | 107 | 3 | IPR008952 | |
| Domain | Tetraspannin | 8.80e-04 | 33 | 107 | 3 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 8.80e-04 | 33 | 107 | 3 | IPR018499 | |
| Domain | STAT_TF_alpha | 8.90e-04 | 8 | 107 | 2 | IPR013800 | |
| Domain | Ptc/Disp | 1.14e-03 | 9 | 107 | 2 | IPR003392 | |
| Domain | Patched | 1.14e-03 | 9 | 107 | 2 | PF02460 | |
| Domain | Frizzled | 1.73e-03 | 11 | 107 | 2 | IPR000539 | |
| Domain | Frizzled | 1.73e-03 | 11 | 107 | 2 | PF01534 | |
| Domain | Frizzled | 1.73e-03 | 11 | 107 | 2 | SM01330 | |
| Domain | IG_LIKE | 2.05e-03 | 491 | 107 | 9 | PS50835 | |
| Domain | OA_transporter | 2.07e-03 | 12 | 107 | 2 | IPR004156 | |
| Domain | OATP | 2.07e-03 | 12 | 107 | 2 | PF03137 | |
| Domain | Ig-like_dom | 2.41e-03 | 503 | 107 | 9 | IPR007110 | |
| Domain | SSD | 2.43e-03 | 13 | 107 | 2 | IPR000731 | |
| Domain | SSD | 2.43e-03 | 13 | 107 | 2 | PS50156 | |
| Domain | P_typ_ATPase_c | 2.83e-03 | 14 | 107 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.83e-03 | 14 | 107 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.83e-03 | 14 | 107 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.83e-03 | 14 | 107 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.83e-03 | 14 | 107 | 2 | PF16209 | |
| Domain | 2pore_dom_K_chnl | 3.25e-03 | 15 | 107 | 2 | IPR003280 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 6.42e-11 | 25 | 80 | 7 | M47934 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 7.06e-10 | 19 | 80 | 6 | MM15194 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | FLT4 PDGFRB MATK NTRK3 STAT3 STAT6 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.07e-08 | 418 | 80 | 15 | MM15587 |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.36e-08 | 55 | 80 | 7 | M47952 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | FLT4 PDGFRB MATK NTRK3 STAT3 STAT6 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 3.90e-08 | 532 | 80 | 16 | M27870 |
| Pathway | REACTOME_NEURONAL_SYSTEM | NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 KCNJ18 | 4.59e-08 | 335 | 80 | 13 | MM14503 |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 5.67e-08 | 19 | 80 | 5 | M27452 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 7.84e-08 | 98 | 80 | 8 | MM14545 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.18e-07 | 144 | 80 | 9 | MM14501 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.60e-07 | 50 | 80 | 6 | M48087 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 4.04e-07 | 121 | 80 | 8 | M39823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 4.26e-07 | 83 | 80 | 7 | M47961 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 6.61e-07 | 30 | 80 | 5 | MM14542 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 6.88e-07 | 89 | 80 | 7 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 8.63e-07 | 92 | 80 | 7 | M47927 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.33e-06 | 98 | 80 | 7 | M39830 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.70e-06 | 36 | 80 | 5 | MM14544 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.75e-06 | 5 | 80 | 3 | M48987 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 1.86e-06 | 103 | 80 | 7 | M1073 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.94e-06 | 211 | 80 | 9 | MM14502 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 KCNK4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 | 3.22e-06 | 411 | 80 | 12 | M735 |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 3.31e-06 | 41 | 80 | 5 | MM15075 | |
| Pathway | PID_TCPTP_PATHWAY | 3.74e-06 | 42 | 80 | 5 | M91 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 4.12e-06 | 116 | 80 | 7 | MM15863 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 4.22e-06 | 43 | 80 | 5 | M881 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 4.36e-06 | 117 | 80 | 7 | M39530 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 4.74e-06 | 44 | 80 | 5 | MM15709 | |
| Pathway | WP_CANCER_PATHWAYS | FLT4 ABL1 PDGFRB STAT3 STAT6 FZD8 JAK3 FZD5 FGFR1 FGFR3 FGFR4 KIT ALK | 5.02e-06 | 507 | 80 | 13 | M48302 |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 7.36e-06 | 83 | 80 | 6 | M27163 | |
| Pathway | WP_RAS_SIGNALING | 9.41e-06 | 184 | 80 | 8 | M39764 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | PDGFRB NTRK3 PSMD1 STAT3 FZD8 FZD5 KDR FGFR1 FGFR3 FGFR4 KIT ALK | 1.11e-05 | 464 | 80 | 12 | M27547 |
| Pathway | WP_IL4_SIGNALING | 1.32e-05 | 54 | 80 | 5 | M39720 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.06e-05 | 205 | 80 | 8 | M752 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.22e-05 | 60 | 80 | 5 | MM15708 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.55e-05 | 103 | 80 | 6 | MM15196 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLCO1B3 PSMD1 SLCO1B1 SLC5A5 SLC9B1 SLC9A4 ATP8A1 TRPM3 SLC35B4 SLC35A2 SLC9B2 ATP11A SLC33A1 SLC44A3 | 2.57e-05 | 681 | 80 | 14 | MM14985 |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 3.70e-05 | 110 | 80 | 6 | M27162 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 4.12e-05 | 367 | 80 | 10 | M48346 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 4.31e-05 | 113 | 80 | 6 | MM14783 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 4.40e-05 | 35 | 80 | 4 | M1075 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 5.04e-05 | 71 | 80 | 5 | MM15947 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.16e-05 | 302 | 80 | 9 | M39719 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 5.49e-05 | 118 | 80 | 6 | M713 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.51e-05 | 37 | 80 | 4 | MM14564 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO1B3 SLCO1B1 SLC5A5 SLC9A4 SLC35B4 SLC35A2 SLC33A1 SLC44A3 | 5.97e-05 | 238 | 80 | 8 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLCO1B3 PSMD1 SLCO1B1 SLC5A5 SLC9B1 SLC9A4 ATP8A1 TRPM3 SLC35B4 SLC35A2 SLC9B2 ATP11A SLC33A1 SLC44A3 | 6.01e-05 | 736 | 80 | 14 | M27287 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO1B3 SLCO1B1 SLC5A5 SLC9A4 SLC35B4 SLC35A2 SLC33A1 SLC44A3 | 8.20e-05 | 249 | 80 | 8 | M5988 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 9.28e-05 | 326 | 80 | 9 | MM15917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 9.34e-05 | 16 | 80 | 3 | M47823 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 9.42e-05 | 130 | 80 | 6 | M27454 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.00e-04 | 43 | 80 | 4 | M954 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.00e-04 | 43 | 80 | 4 | M508 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.25e-04 | 339 | 80 | 9 | M39736 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.42e-04 | 140 | 80 | 6 | M42572 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.44e-04 | 270 | 80 | 8 | M15514 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.81e-04 | 439 | 80 | 10 | M42563 | |
| Pathway | WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA | 1.87e-04 | 20 | 80 | 3 | M39381 | |
| Pathway | PID_KIT_PATHWAY | 2.12e-04 | 52 | 80 | 4 | M231 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.45e-04 | 99 | 80 | 5 | M27474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 2.87e-04 | 23 | 80 | 3 | M47904 | |
| Pathway | PID_SHP2_PATHWAY | 3.02e-04 | 57 | 80 | 4 | M100 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.45e-04 | 165 | 80 | 6 | MM15026 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 3.68e-04 | 60 | 80 | 4 | M976 | |
| Pathway | PID_TRKR_PATHWAY | 3.93e-04 | 61 | 80 | 4 | M187 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 4.44e-04 | 63 | 80 | 4 | M635 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 4.44e-04 | 63 | 80 | 4 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 4.44e-04 | 63 | 80 | 4 | M39646 | |
| Pathway | WP_BURN_WOUND_HEALING | 4.51e-04 | 113 | 80 | 5 | M42571 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 4.67e-04 | 27 | 80 | 3 | MM14712 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 5.01e-04 | 177 | 80 | 6 | M27476 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.02e-04 | 325 | 80 | 8 | M12868 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 5.31e-04 | 66 | 80 | 4 | MM15875 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.50e-04 | 118 | 80 | 5 | M39852 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 5.62e-04 | 252 | 80 | 7 | MM15585 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 5.78e-04 | 29 | 80 | 3 | M39616 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 5.78e-04 | 29 | 80 | 3 | M779 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 6.40e-04 | 30 | 80 | 3 | M42517 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 7.05e-04 | 31 | 80 | 3 | M47396 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 7.05e-04 | 31 | 80 | 3 | M47964 | |
| Pathway | PID_NCADHERIN_PATHWAY | 8.49e-04 | 33 | 80 | 3 | M266 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 8.71e-04 | 8 | 80 | 2 | MM1576 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 8.71e-04 | 8 | 80 | 2 | M22063 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 8.71e-04 | 8 | 80 | 2 | M27433 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 8.71e-04 | 8 | 80 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 8.71e-04 | 8 | 80 | 2 | MM14753 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.81e-04 | 272 | 80 | 7 | M13380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 1.01e-03 | 35 | 80 | 3 | M47379 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.03e-03 | 203 | 80 | 6 | M5485 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.12e-03 | 9 | 80 | 2 | M45020 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.12e-03 | 9 | 80 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.12e-03 | 9 | 80 | 2 | MM1419 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 1.12e-03 | 9 | 80 | 2 | M27688 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 1.12e-03 | 9 | 80 | 2 | MM15421 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.12e-03 | 9 | 80 | 2 | M8066 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.19e-03 | 37 | 80 | 3 | M39506 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.32e-03 | 84 | 80 | 4 | M39839 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 1.35e-03 | 144 | 80 | 5 | M39691 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 1.37e-03 | 85 | 80 | 4 | MM15041 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.39e-03 | 10 | 80 | 2 | M27898 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 1.39e-03 | 10 | 80 | 2 | M137 | |
| Pubmed | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.49e-26 | 83 | 110 | 17 | 11114734 | |
| Pubmed | 4.40e-12 | 51 | 110 | 8 | 26764350 | ||
| Pubmed | 4.46e-11 | 40 | 110 | 7 | 30898150 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 19636022 | ||
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 20798526 | ||
| Pubmed | 3.10e-10 | 28 | 110 | 6 | 18593464 | ||
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 4.72e-10 | 5 | 110 | 4 | 21633168 | |
| Pubmed | Elevated synaptic vesicle release probability in synaptophysin/gyrin family quadruple knockouts. | 4.72e-10 | 5 | 110 | 4 | 31090538 | |
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 7.39e-10 | 32 | 110 | 6 | 7542761 | |
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 7580148 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 3.29e-09 | 7 | 110 | 4 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 3.29e-09 | 7 | 110 | 4 | 9651535 | |
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 1310861 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.18e-08 | 9 | 110 | 4 | 9051806 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.46e-08 | 25 | 110 | 5 | 15254900 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 1.57e-08 | 90 | 110 | 7 | 16273093 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 3.00e-08 | 372 | 110 | 11 | 22939624 | |
| Pubmed | Differential polyamine sensitivity in inwardly rectifying Kir2 potassium channels. | 3.08e-08 | 3 | 110 | 3 | 16373386 | |
| Pubmed | Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. | 3.08e-08 | 3 | 110 | 3 | 12032359 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 8083233 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 11410627 | ||
| Pubmed | Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1. | 3.08e-08 | 3 | 110 | 3 | 29454091 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 12928441 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 10904001 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 3.08e-08 | 3 | 110 | 3 | 7523595 | |
| Pubmed | Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1. | 3.08e-08 | 3 | 110 | 3 | 16258766 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 17640933 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 10358037 | ||
| Pubmed | Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. | 4.60e-08 | 12 | 110 | 4 | 10918587 | |
| Pubmed | 4.60e-08 | 12 | 110 | 4 | 11891216 | ||
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 25218043 | ||
| Pubmed | 9.25e-08 | 14 | 110 | 4 | 11350938 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9619499 | ||
| Pubmed | Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. | 1.23e-07 | 4 | 110 | 3 | 15958527 | |
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 1.23e-07 | 4 | 110 | 3 | 36142417 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9664689 | ||
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 1.23e-07 | 4 | 110 | 3 | 18776942 | |
| Pubmed | VEGFR3 modulates brain microvessel branching in a mouse model of 22q11.2 deletion syndrome. | 1.23e-07 | 4 | 110 | 3 | 36216515 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 9212826 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 11759058 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 12644244 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 27154171 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 1.23e-07 | 4 | 110 | 3 | 12373339 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 1.23e-07 | 4 | 110 | 3 | 17304337 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 14745431 | ||
| Pubmed | Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. | 1.26e-07 | 15 | 110 | 4 | 10479680 | |
| Pubmed | 1.26e-07 | 15 | 110 | 4 | 16382105 | ||
| Pubmed | A high-resolution molecular atlas of the fetal mouse lower urogenital tract. | 1.47e-07 | 75 | 110 | 6 | 21905163 | |
| Pubmed | 2.80e-07 | 18 | 110 | 4 | 34455539 | ||
| Pubmed | PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. | 2.80e-07 | 18 | 110 | 4 | 21511879 | |
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.06e-07 | 5 | 110 | 3 | 15987787 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 16177047 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 27206683 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 9760194 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 8288598 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 3.06e-07 | 5 | 110 | 3 | 11566361 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 3.06e-07 | 5 | 110 | 3 | 27078042 | |
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 3.06e-07 | 5 | 110 | 3 | 1717158 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 3.06e-07 | 5 | 110 | 3 | 16091423 | |
| Pubmed | Heteromer formation of delta2 glutamate receptors with AMPA or kainate receptors. | 3.06e-07 | 5 | 110 | 3 | 12573530 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 16825495 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 29326130 | ||
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.06e-07 | 5 | 110 | 3 | 9771645 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 28094278 | ||
| Pubmed | Inward rectifier potassium channel Kir2.2 is associated with synapse-associated protein SAP97. | 3.06e-07 | 5 | 110 | 3 | 11181181 | |
| Pubmed | Identification of novel protein kinases expressed in the myocardium of the developing mouse heart. | 4.41e-07 | 20 | 110 | 4 | 7893599 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 10572038 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 18753255 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 19515808 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 6.11e-07 | 6 | 110 | 3 | 24026051 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 16365308 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 6.11e-07 | 6 | 110 | 3 | 16436388 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 19232523 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 19966287 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 24184958 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 9010207 | ||
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 29720668 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.63e-07 | 22 | 110 | 4 | 18391953 | |
| Pubmed | Fgf9 signalling stimulates Spred and Sprouty expression in embryonic mouse pancreas mesenchyme. | 8.01e-07 | 23 | 110 | 4 | 20934536 | |
| Pubmed | 8.01e-07 | 23 | 110 | 4 | 8464923 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 9.59e-07 | 24 | 110 | 4 | 35746896 | |
| Pubmed | Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. | 1.07e-06 | 7 | 110 | 3 | 8626374 | |
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 16772167 | ||
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 8959336 | ||
| Pubmed | 1.07e-06 | 7 | 110 | 3 | 19815557 | ||
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 1.07e-06 | 7 | 110 | 3 | 20131355 | |
| Pubmed | 1.14e-06 | 25 | 110 | 4 | 17185339 | ||
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 18187602 | ||
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 17623664 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 1.70e-06 | 8 | 110 | 3 | 16989989 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 1.70e-06 | 8 | 110 | 3 | 8163463 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 28467822 | ||
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 28389228 | ||
| Pubmed | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. | 1.70e-06 | 8 | 110 | 3 | 11940572 | |
| Pubmed | Abl family kinases regulate endothelial barrier function in vitro and in mice. | 1.70e-06 | 8 | 110 | 3 | 24367707 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 2.55e-06 | 9 | 110 | 3 | 10751173 | |
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 15229180 | ||
| Pubmed | Hypertonicity activates Na+/H+ exchange through Janus kinase 2 and calmodulin. | 2.55e-06 | 9 | 110 | 3 | 12626508 | |
| Pubmed | 2.55e-06 | 9 | 110 | 3 | 10781830 | ||
| Interaction | SEC24A interactions | FLT4 PDGFRB ST7 NTRK3 ROR1 DDR2 PSMD1 STAT6 KCNA3 KCNJ10 FGFR1 FGFR3 FGFR4 ALK | 1.25e-11 | 224 | 106 | 14 | int:SEC24A |
| Interaction | FAM171A1 interactions | 9.78e-10 | 89 | 106 | 9 | int:FAM171A1 | |
| Interaction | PIK3R2 interactions | FLT4 ABL1 PDGFRB NTRK3 ROR1 STAT3 JAK3 FGFR1 FGFR4 LTK KIT ALK | 3.14e-09 | 230 | 106 | 12 | int:PIK3R2 |
| Interaction | FRS2 interactions | 3.33e-09 | 102 | 106 | 9 | int:FRS2 | |
| Interaction | PIK3R1 interactions | FLT4 ABL1 PDGFRB NTRK3 ROR1 STAT3 JAK3 FER FES FGFR1 FGFR3 FGFR4 LTK KIT ALK | 4.21e-09 | 412 | 106 | 15 | int:PIK3R1 |
| Interaction | SHB interactions | 1.40e-08 | 84 | 106 | 8 | int:SHB | |
| Interaction | FES interactions | 3.15e-08 | 61 | 106 | 7 | int:FES | |
| Interaction | GAB1 interactions | 3.44e-08 | 178 | 106 | 10 | int:GAB1 | |
| Interaction | SEC24B interactions | FLT4 PDGFRB ST7 NTRK3 DDR2 KCNA3 KCNJ10 FGFR1 FGFR3 FGFR4 ALK | 5.59e-08 | 240 | 106 | 11 | int:SEC24B |
| Interaction | HSPA1B interactions | FLT4 PDGFRB NTRK3 ROR1 DDR2 KCNA3 KDR FGFR1 FGFR3 FGFR4 LTK ALK | 6.24e-08 | 301 | 106 | 12 | int:HSPA1B |
| Interaction | PTPN11 interactions | FLT4 ABL1 PDGFRB NTRK3 STAT3 KCNA3 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 6.99e-08 | 368 | 106 | 13 | int:PTPN11 |
| Interaction | EPCAM interactions | 8.98e-08 | 22 | 106 | 5 | int:EPCAM | |
| Interaction | ABL2 interactions | 9.50e-08 | 107 | 106 | 8 | int:ABL2 | |
| Interaction | HYOU1 interactions | FLT4 PDGFRB NTRK3 ROR1 DDR2 VWDE KCNA3 FGFR1 FGFR3 FGFR4 LTK ALK | 1.10e-07 | 317 | 106 | 12 | int:HYOU1 |
| Interaction | ACBD3 interactions | 1.21e-07 | 259 | 106 | 11 | int:ACBD3 | |
| Interaction | PGRMC2 interactions | SLC16A13 FLT4 ST7 NTRK3 TSPAN2 KCNA3 SLC9B2 FGFR1 FGFR3 FGFR4 ALK | 2.74e-07 | 281 | 106 | 11 | int:PGRMC2 |
| Interaction | UNC5B interactions | 2.96e-07 | 84 | 106 | 7 | int:UNC5B | |
| Interaction | KIT interactions | 3.17e-07 | 125 | 106 | 8 | int:KIT | |
| Interaction | SRPRA interactions | 3.27e-07 | 286 | 106 | 11 | int:SRPRA | |
| Interaction | SHC1 interactions | FLT4 ABL1 PDGFRB NTRK3 DDR2 CUL9 KDR FGFR1 FGFR4 LTK KIT ALK | 4.55e-07 | 362 | 106 | 12 | int:SHC1 |
| Interaction | NCK1 interactions | 6.48e-07 | 244 | 106 | 10 | int:NCK1 | |
| Interaction | SNTB1 interactions | 9.78e-07 | 63 | 106 | 6 | int:SNTB1 | |
| Interaction | PLCG1 interactions | 1.33e-06 | 264 | 106 | 10 | int:PLCG1 | |
| Interaction | FAM171A2 interactions | 2.10e-06 | 112 | 106 | 7 | int:FAM171A2 | |
| Interaction | JAK2 interactions | 2.60e-06 | 165 | 106 | 8 | int:JAK2 | |
| Interaction | SEC23B interactions | 2.64e-06 | 222 | 106 | 9 | int:SEC23B | |
| Interaction | HLA-A interactions | 2.98e-06 | 289 | 106 | 10 | int:HLA-A | |
| Interaction | MATK interactions | 3.01e-06 | 43 | 106 | 5 | int:MATK | |
| Interaction | STAT3 interactions | PDGFRB STAT3 STAT6 JAK3 KCNA3 FER FES KDR FGFR1 FGFR3 FGFR4 ALK | 4.00e-06 | 446 | 106 | 12 | int:STAT3 |
| Interaction | ALDH3A2 interactions | 4.67e-06 | 304 | 106 | 10 | int:ALDH3A2 | |
| Interaction | FGF6 interactions | 4.87e-06 | 7 | 106 | 3 | int:FGF6 | |
| Interaction | FGF18 interactions | 4.87e-06 | 7 | 106 | 3 | int:FGF18 | |
| Interaction | DLG1 interactions | 4.99e-06 | 240 | 106 | 9 | int:DLG1 | |
| Interaction | STIM1 interactions | FLT4 PDGFRB ST7 NTRK3 DDR2 GRIA2 KCNA3 FGFR1 FGFR3 SLC33A1 ALK | 6.33e-06 | 388 | 106 | 11 | int:STIM1 |
| Interaction | NBEA interactions | 7.49e-06 | 89 | 106 | 6 | int:NBEA | |
| Interaction | FGF5 interactions | 7.77e-06 | 8 | 106 | 3 | int:FGF5 | |
| Interaction | FGF23 interactions | 7.77e-06 | 8 | 106 | 3 | int:FGF23 | |
| Interaction | HSP90AA1 interactions | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 PSMD1 STAT3 FANCC JAK3 KCNA3 HPX FER FES KDR FGFR1 FGFR3 FGFR4 ALK | 8.26e-06 | 1263 | 106 | 20 | int:HSP90AA1 |
| Interaction | EGLN1 interactions | 8.52e-06 | 91 | 106 | 6 | int:EGLN1 | |
| Interaction | MERTK interactions | 9.23e-06 | 140 | 106 | 7 | int:MERTK | |
| Interaction | SYAP1 interactions | 1.11e-05 | 144 | 106 | 7 | int:SYAP1 | |
| Interaction | GRIP1 interactions | 1.16e-05 | 96 | 106 | 6 | int:GRIP1 | |
| Interaction | WASF2 interactions | 1.21e-05 | 146 | 106 | 7 | int:WASF2 | |
| Interaction | ERBB2 interactions | FLT4 ABL1 PDGFRB MATK NTRK3 STAT3 KCNA3 FER FES FGFR1 FGFR3 FGFR4 ALK | 1.32e-05 | 589 | 106 | 13 | int:ERBB2 |
| Interaction | ALK interactions | 1.33e-05 | 271 | 106 | 9 | int:ALK | |
| Interaction | CALM3 interactions | 1.34e-05 | 343 | 106 | 10 | int:CALM3 | |
| Interaction | PTPN6 interactions | 1.62e-05 | 278 | 106 | 9 | int:PTPN6 | |
| Interaction | ARF4 interactions | 1.77e-05 | 281 | 106 | 9 | int:ARF4 | |
| Interaction | ERBB3 interactions | 1.80e-05 | 355 | 106 | 10 | int:ERBB3 | |
| Interaction | RET interactions | 1.92e-05 | 284 | 106 | 9 | int:RET | |
| Interaction | ERRFI1 interactions | 2.16e-05 | 107 | 106 | 6 | int:ERRFI1 | |
| Interaction | CSF2RB interactions | 2.32e-05 | 32 | 106 | 4 | int:CSF2RB | |
| Interaction | GRIK2 interactions | 2.32e-05 | 32 | 106 | 4 | int:GRIK2 | |
| Interaction | VEZT interactions | 2.38e-05 | 162 | 106 | 7 | int:VEZT | |
| Interaction | ARFGAP3 interactions | 2.40e-05 | 109 | 106 | 6 | int:ARFGAP3 | |
| Interaction | PTPN1 interactions | FLT4 ABL1 PDGFRB ST7 NTRK3 DDR2 GRIA2 STAT3 KCNA3 FGFR1 LTK SLC33A1 ALK | 2.45e-05 | 625 | 106 | 13 | int:PTPN1 |
| Interaction | COPB1 interactions | 2.52e-05 | 294 | 106 | 9 | int:COPB1 | |
| Interaction | KLB interactions | 3.01e-05 | 12 | 106 | 3 | int:KLB | |
| Interaction | PTK7 interactions | 3.01e-05 | 168 | 106 | 7 | int:PTK7 | |
| Interaction | CDK5RAP3 interactions | 3.01e-05 | 168 | 106 | 7 | int:CDK5RAP3 | |
| Interaction | GOPC interactions | 3.20e-05 | 303 | 106 | 9 | int:GOPC | |
| Interaction | CBLB interactions | 3.25e-05 | 115 | 106 | 6 | int:CBLB | |
| Interaction | FGFR2 interactions | 3.86e-05 | 239 | 106 | 8 | int:FGFR2 | |
| Interaction | NPY4R interactions | 3.89e-05 | 13 | 106 | 3 | int:NPY4R | |
| Interaction | CDCA3 interactions | 4.20e-05 | 177 | 106 | 7 | int:CDCA3 | |
| Interaction | NUP155 interactions | 4.28e-05 | 477 | 106 | 11 | int:NUP155 | |
| Interaction | KL interactions | 4.94e-05 | 14 | 106 | 3 | int:KL | |
| Interaction | AQP6 interactions | SLC16A13 TMEM50A UNC93A CYB561A3 TBC1D20 TMEM203 SLC35B4 AGMO SYNGR1 | 6.19e-05 | 330 | 106 | 9 | int:AQP6 |
| Interaction | EMD interactions | FLT4 ABL1 ST7 NTRK3 GRIA1 GRIA2 KCNA3 KCNJ12 KDR FGFR3 FGFR4 KCNJ18 SLC33A1 ALK | 6.64e-05 | 789 | 106 | 14 | int:EMD |
| Interaction | FGF7 interactions | 7.54e-05 | 16 | 106 | 3 | int:FGF7 | |
| Interaction | FGF9 interactions | 7.54e-05 | 16 | 106 | 3 | int:FGF9 | |
| Interaction | ERBIN interactions | 7.98e-05 | 265 | 106 | 8 | int:ERBIN | |
| Interaction | STAT1 interactions | 8.14e-05 | 342 | 106 | 9 | int:STAT1 | |
| Interaction | JAK3 interactions | 8.30e-05 | 136 | 106 | 6 | int:JAK3 | |
| Interaction | NTPCR interactions | 8.30e-05 | 136 | 106 | 6 | int:NTPCR | |
| Interaction | GRB2 interactions | FLT4 ABL1 PDGFRB NTRK3 DDR2 TSPAN2 SYP KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 8.33e-05 | 806 | 106 | 14 | int:GRB2 |
| Interaction | PIK3R3 interactions | 8.52e-05 | 198 | 106 | 7 | int:PIK3R3 | |
| Interaction | EHBP1 interactions | 8.64e-05 | 137 | 106 | 6 | int:EHBP1 | |
| Interaction | MST1R interactions | 9.08e-05 | 200 | 106 | 7 | int:MST1R | |
| Interaction | SLCO1B1 interactions | 9.12e-05 | 17 | 106 | 3 | int:SLCO1B1 | |
| Interaction | SEC63 interactions | 9.29e-05 | 348 | 106 | 9 | int:SEC63 | |
| Interaction | STIM2 interactions | 9.74e-05 | 140 | 106 | 6 | int:STIM2 | |
| Interaction | CNP interactions | 9.96e-05 | 203 | 106 | 7 | int:CNP | |
| Interaction | TMEM14B interactions | SLC16A13 TMEM50A UNC93A TSPAN2 TBC1D20 TMEM203 SYNGR1 TMEM50B | 1.14e-04 | 279 | 106 | 8 | int:TMEM14B |
| Interaction | SH3BP2 interactions | 1.18e-04 | 48 | 106 | 4 | int:SH3BP2 | |
| Interaction | FGFR1 interactions | FLT4 PDGFRB MATK ROR1 STAT3 HPX FES FGFR1 FGFR3 FGFR4 KIT ALK | 1.22e-04 | 632 | 106 | 12 | int:FGFR1 |
| Interaction | ANKLE2 interactions | 1.23e-04 | 210 | 106 | 7 | int:ANKLE2 | |
| Interaction | STAM2 interactions | 1.27e-04 | 147 | 106 | 6 | int:STAM2 | |
| Interaction | DLG4 interactions | GRIA1 GRIA2 GRIK1 GRIK2 PRR7 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 | 1.29e-04 | 449 | 106 | 10 | int:DLG4 |
| Interaction | USO1 interactions | 1.42e-04 | 215 | 106 | 7 | int:USO1 | |
| Interaction | GORASP2 interactions | 1.45e-04 | 369 | 106 | 9 | int:GORASP2 | |
| Interaction | ARHGEF10 interactions | 1.46e-04 | 95 | 106 | 5 | int:ARHGEF10 | |
| Interaction | MET interactions | 1.49e-04 | 290 | 106 | 8 | int:MET | |
| Interaction | GPRIN1 interactions | 1.53e-04 | 96 | 106 | 5 | int:GPRIN1 | |
| Interaction | VEGFC interactions | 1.63e-04 | 4 | 106 | 2 | int:VEGFC | |
| Interaction | KCNJ18 interactions | 1.63e-04 | 4 | 106 | 2 | int:KCNJ18 | |
| Interaction | HSD17B12 interactions | 1.64e-04 | 220 | 106 | 7 | int:HSD17B12 | |
| Interaction | VAPB interactions | 1.68e-04 | 464 | 106 | 10 | int:VAPB | |
| Interaction | CASK interactions | 1.69e-04 | 221 | 106 | 7 | int:CASK | |
| Interaction | CCDC115 interactions | 1.77e-04 | 99 | 106 | 5 | int:CCDC115 | |
| Cytoband | 4q11-q12 | 1.70e-05 | 3 | 110 | 2 | 4q11-q12 | |
| Cytoband | Xp11.23-p11.22 | 1.19e-04 | 7 | 110 | 2 | Xp11.23-p11.22 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | FLT4 PDGFRB NTRK3 ROR1 DDR2 KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 1.20e-19 | 40 | 80 | 12 | 321 |
| GeneFamily | Solute carriers | SLC16A13 SLC7A13 SLC16A9 SLCO1B3 SLCO1B1 SLC35F5 SLC5A5 SLC9B1 SLC9A4 SLC16A6 SLC35B4 SLC35A2 SLC9B2 SLC33A1 SLC44A3 | 1.73e-10 | 395 | 80 | 15 | 752 |
| GeneFamily | Potassium voltage-gated channel subfamily J | 6.28e-09 | 16 | 80 | 5 | 276 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.59e-07 | 161 | 80 | 8 | 593 | |
| GeneFamily | SH2 domain containing | 5.63e-06 | 101 | 80 | 6 | 741 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 1.15e-04 | 4 | 80 | 2 | 1200 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.92e-04 | 5 | 80 | 2 | 1199 | |
| GeneFamily | CD molecules|Tetraspanins | 4.14e-04 | 33 | 80 | 3 | 768 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.04e-03 | 11 | 80 | 2 | 286 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.79e-03 | 394 | 80 | 7 | 471 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 1.96e-03 | 15 | 80 | 2 | 277 | |
| GeneFamily | ATPase phospholipid transporting | 1.96e-03 | 15 | 80 | 2 | 1210 | |
| GeneFamily | Olfactory receptors, family 9 | 4.61e-03 | 23 | 80 | 2 | 156 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 4.61e-03 | 23 | 80 | 2 | 1288 | |
| GeneFamily | Immunoglobulin like domain containing | 1.06e-02 | 193 | 80 | 4 | 594 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 2.87e-07 | 34 | 109 | 5 | M45005 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.58e-06 | 135 | 109 | 7 | M5825 | |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 3.94e-06 | 26 | 109 | 4 | M16488 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | SLC16A9 MATK SIDT1 GRIK2 TRPM3 KCNJ10 SYNGR3 SYPL2 HRH1 LTK CCDC17 | 6.82e-06 | 493 | 109 | 11 | M1951 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | SLC16A9 MATK SIDT1 GRIK2 TRPM3 KCNJ10 SYNGR3 SYPL2 HRH1 LTK CCDC17 | 8.39e-06 | 504 | 109 | 11 | MM830 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 8.49e-06 | 323 | 109 | 9 | M9150 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 9.30e-06 | 32 | 109 | 4 | MM17 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DRD5 SLC16A9 ROR1 SIDT1 KCNA3 TRPM3 FZD5 KCNJ4 KCNJ10 SYNGR3 SYNGR2 SYPL2 HRH1 KDR FGFR3 KIT | 9.39e-06 | 1074 | 109 | 16 | M1941 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.68e-05 | 268 | 109 | 8 | M45796 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 1.77e-05 | 130 | 109 | 6 | M40147 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN | 1.93e-05 | 132 | 109 | 6 | M15410 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | NTRK3 TMEM114 GRIA2 NAGS SLC5A5 TRPM3 KCNJ10 SYPL2 HRH1 FGFR4 ALK | 3.64e-05 | 591 | 109 | 11 | M2019 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | NTRK3 TMEM114 GRIA2 NAGS SLC5A5 TRPM3 KCNJ10 SYPL2 HRH1 FGFR4 ALK | 4.24e-05 | 601 | 109 | 11 | MM866 |
| Coexpression | HAN_SATB1_TARGETS_UP | B3GALNT1 TMEM45A SLCO1B3 JAK3 SULT1C2 SYNGR3 SYNGR1 HRH1 SLC33A1 | 7.27e-05 | 425 | 109 | 9 | M9639 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | B3GALNT1 ST7 GRIA1 PSMD1 GRIK1 STAT3 STAT6 FADS1 SYNGR1 HRH1 FGFR1 ALK | 1.07e-04 | 786 | 109 | 12 | M2388 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | B3GALNT1 TMEM45A PDGFRB ST7 NTRK3 ROR1 DDR2 GRIA1 GRIA2 GRIK2 ATP8A1 UPK1B SCN7A SYP KIT DISP1 | 6.29e-07 | 734 | 105 | 16 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | B3GALNT1 TMEM45A ST7 NTRK3 ROR1 DDR2 GRIA2 ATP8A1 UPK1B SYP DISP1 | 2.30e-06 | 371 | 105 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 4.03e-05 | 127 | 105 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | cerebral cortex | DRD5 MATK NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 XKR4 SYNPR KCNK4 PRR7 KCNJ4 KCNJ10 SYNGR3 SLC9B2 KCNK10 SYP CERS1 ALK | 6.68e-05 | 1428 | 105 | 19 | cerebral cortex |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.19e-08 | 173 | 110 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-08 | 186 | 110 | 8 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-08 | 188 | 110 | 8 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-08 | 196 | 110 | 8 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 161 | 110 | 7 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 161 | 110 | 7 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 161 | 110 | 7 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 161 | 110 | 7 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.82e-07 | 165 | 110 | 7 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-07 | 168 | 110 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-07 | 170 | 110 | 7 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-07 | 170 | 110 | 7 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-07 | 170 | 110 | 7 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-07 | 171 | 110 | 7 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-07 | 176 | 110 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 2.93e-07 | 177 | 110 | 7 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-07 | 180 | 110 | 7 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-07 | 183 | 110 | 7 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-07 | 185 | 110 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-07 | 185 | 110 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-07 | 185 | 110 | 7 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 186 | 110 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 186 | 110 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.25e-07 | 187 | 110 | 7 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-07 | 190 | 110 | 7 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-07 | 190 | 110 | 7 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-07 | 190 | 110 | 7 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-07 | 193 | 110 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.25e-07 | 193 | 110 | 7 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.25e-07 | 193 | 110 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-07 | 193 | 110 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-07 | 193 | 110 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-07 | 193 | 110 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-07 | 193 | 110 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.44e-07 | 194 | 110 | 7 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.44e-07 | 194 | 110 | 7 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.83e-07 | 196 | 110 | 7 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.67e-07 | 200 | 110 | 7 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.67e-07 | 200 | 110 | 7 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.67e-07 | 200 | 110 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.67e-07 | 200 | 110 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.67e-07 | 200 | 110 | 7 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.67e-07 | 200 | 110 | 7 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-07 | 71 | 110 | 5 | cf4c8715c2bd77fc86e45cc01bcc7aa6044e091d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 143 | 110 | 6 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 152 | 110 | 6 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 152 | 110 | 6 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 158 | 110 | 6 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 158 | 110 | 6 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-06 | 173 | 110 | 6 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.56e-06 | 173 | 110 | 6 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.87e-06 | 175 | 110 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.87e-06 | 175 | 110 | 6 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.87e-06 | 175 | 110 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.03e-06 | 176 | 110 | 6 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.20e-06 | 177 | 110 | 6 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 178 | 110 | 6 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.37e-06 | 178 | 110 | 6 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-06 | 179 | 110 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.54e-06 | 179 | 110 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 180 | 110 | 6 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | 15-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 5.72e-06 | 180 | 110 | 6 | 99e2db9ad8e09fedc3542233553acece69f579f1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-06 | 180 | 110 | 6 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 5.72e-06 | 180 | 110 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 181 | 110 | 6 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.91e-06 | 181 | 110 | 6 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.91e-06 | 181 | 110 | 6 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.91e-06 | 181 | 110 | 6 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-06 | 182 | 110 | 6 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-06 | 182 | 110 | 6 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.10e-06 | 182 | 110 | 6 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 183 | 110 | 6 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-06 | 183 | 110 | 6 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-06 | 184 | 110 | 6 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.49e-06 | 184 | 110 | 6 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.70e-06 | 185 | 110 | 6 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.70e-06 | 185 | 110 | 6 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.70e-06 | 185 | 110 | 6 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-06 | 186 | 110 | 6 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-06 | 186 | 110 | 6 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-06 | 186 | 110 | 6 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.12e-06 | 187 | 110 | 6 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 187 | 110 | 6 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 187 | 110 | 6 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 187 | 110 | 6 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.12e-06 | 187 | 110 | 6 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 187 | 110 | 6 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 188 | 110 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 188 | 110 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 7.34e-06 | 188 | 110 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 188 | 110 | 6 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.34e-06 | 188 | 110 | 6 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 189 | 110 | 6 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 189 | 110 | 6 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-06 | 189 | 110 | 6 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-06 | 190 | 110 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.80e-06 | 190 | 110 | 6 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-06 | 190 | 110 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.03e-06 | 191 | 110 | 6 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| Computational | Genes in the cancer module 85. | 2.00e-10 | 51 | 57 | 8 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 5.07e-10 | 57 | 57 | 8 | MODULE_199 | |
| Computational | Porins / transporters. | PDGFRB DDR2 GRIK1 ITGB8 KCNJ2 KCNJ12 SCN7A KDR FGFR1 FGFR3 KIT | 1.08e-08 | 211 | 57 | 11 | MODULE_63 |
| Computational | Genes in the cancer module 80. | 1.38e-08 | 32 | 57 | 6 | MODULE_80 | |
| Computational | RTK signaling. | 1.35e-07 | 46 | 57 | 6 | MODULE_259 | |
| Computational | Genes in the cancer module 200. | 2.59e-07 | 27 | 57 | 5 | MODULE_200 | |
| Computational | Genes in the cancer module 27. | PDGFRB ROR1 DDR2 GRIK1 GRIK2 ITGB8 PTH1R FZD5 HRH1 FGFR1 FGFR3 KIT | 2.59e-07 | 355 | 57 | 12 | MODULE_27 |
| Computational | Genes in the cancer module 51. | 1.17e-06 | 36 | 57 | 5 | MODULE_51 | |
| Computational | Ion channels. | 3.26e-05 | 70 | 57 | 5 | MODULE_316 | |
| Computational | Bone remodeling. | 1.84e-04 | 54 | 57 | 4 | MODULE_234 | |
| Computational | Membranal receptors. | 1.47e-03 | 517 | 57 | 9 | MODULE_64 | |
| Computational | Neighborhood of LTK | 1.83e-03 | 46 | 57 | 3 | GCM_LTK | |
| Computational | Neighborhood of PTPRB | 2.17e-03 | 254 | 57 | 6 | MORF_PTPRB | |
| Computational | Genes in the cancer module 66. | 2.30e-03 | 552 | 57 | 9 | MODULE_66 | |
| Drug | ponatinib | 2.20e-14 | 68 | 109 | 11 | ctd:C545373 | |
| Drug | imatinib | FLT4 ABL1 PDGFRB MATK NTRK3 ROR1 DDR2 STAT3 FZD8 JAK3 FER FES KDR FGFR1 FGFR3 FGFR4 LTK KIT ALK | 2.00e-13 | 430 | 109 | 19 | CID000005291 |
| Drug | 4-AP | GRIA1 GRIA2 GRIK1 KCNK4 KCNA3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 KCNK10 SYP KDR | 4.11e-09 | 258 | 109 | 12 | CID000001727 |
| Drug | orantinib | 7.40e-09 | 6 | 109 | 4 | ctd:C412603 | |
| Drug | Sorafenib | 1.72e-08 | 7 | 109 | 4 | DB00398 | |
| Drug | vandetanib | 2.54e-08 | 99 | 109 | 8 | CID003081361 | |
| Drug | Sunitinib | 3.43e-08 | 8 | 109 | 4 | DB01268 | |
| Drug | SU6668 | 4.44e-08 | 70 | 109 | 7 | CID000206042 | |
| Drug | 1m5b | 6.15e-08 | 9 | 109 | 4 | CID000447081 | |
| Drug | LY339434 | 6.15e-08 | 9 | 109 | 4 | CID006324635 | |
| Drug | Benzoates | 1.02e-07 | 10 | 109 | 4 | ctd:D001565 | |
| Drug | SU11652 | 1.60e-07 | 11 | 109 | 4 | CID005329103 | |
| Drug | sunitinib | 2.13e-07 | 130 | 109 | 8 | CID005329102 | |
| Drug | pazopanib | 2.39e-07 | 12 | 109 | 4 | ctd:C516667 | |
| Drug | Naspm | 3.44e-07 | 13 | 109 | 4 | CID000129695 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 4.25e-07 | 4 | 109 | 3 | ctd:C568950 | |
| Drug | NSC618487 | FLT4 ABL1 PDGFRB MATK GRIK1 STAT3 JAK3 KCNA3 KCNJ2 KCNJ4 KCNJ12 FER FES HRH1 KDR FGFR1 FGFR3 KIT | 4.47e-07 | 933 | 109 | 18 | CID000005279 |
| Drug | gadolinium | 4.98e-07 | 199 | 109 | 9 | CID000023982 | |
| Drug | sodium | SLC16A13 FLT4 SLC7A13 GRIA1 SLCO1B3 GRIA2 GRIK1 SLCO1B1 SLC5A5 KCNA3 TRPM3 KCNJ2 KCNJ4 KCNJ10 KCNJ12 SCN7A SLC9B2 ATP11A | 5.29e-07 | 944 | 109 | 18 | CID000000923 |
| Drug | barium | 5.75e-07 | 148 | 109 | 8 | CID000104810 | |
| Drug | PD173074 | 6.88e-07 | 65 | 109 | 6 | CID000001401 | |
| Drug | Prestwick_517 | 7.83e-07 | 106 | 109 | 7 | CID000003804 | |
| Drug | Potassium | 7.83e-07 | 106 | 109 | 7 | ctd:D011188 | |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 8.65e-07 | 16 | 109 | 4 | ctd:C561052 | |
| Drug | decahydroisoquinoline | 8.65e-07 | 16 | 109 | 4 | CID000097812 | |
| Drug | AC1L3VO5 | 1.44e-06 | 116 | 109 | 7 | CID000123015 | |
| Drug | diazoxide | 1.49e-06 | 227 | 109 | 9 | CID000003019 | |
| Drug | LY382884 | 1.82e-06 | 19 | 109 | 4 | CID000656723 | |
| Drug | barium chloride dihydrate | 1.91e-06 | 43 | 109 | 5 | CID000025157 | |
| Drug | tetraethylammonium | 2.06e-06 | 236 | 109 | 9 | CID000005413 | |
| Drug | Palifermin | 2.11e-06 | 6 | 109 | 3 | DB00039 | |
| Drug | philanthotoxin | 2.40e-06 | 45 | 109 | 5 | CID000115201 | |
| Drug | NS 102 | 3.40e-06 | 22 | 109 | 4 | CID005282252 | |
| Drug | KT5720 | 3.61e-06 | 189 | 109 | 8 | CID000003844 | |
| Drug | imetelstat | 3.68e-06 | 7 | 109 | 3 | ctd:C519562 | |
| Drug | thio-ATPA | 3.68e-06 | 7 | 109 | 3 | CID005289517 | |
| Drug | pD 8 | 4.91e-06 | 24 | 109 | 4 | CID000656948 | |
| Drug | aurintricarboxylic acid | 5.02e-06 | 91 | 109 | 6 | CID000002259 | |
| Drug | crizotinib | 5.48e-06 | 53 | 109 | 5 | ctd:C551994 | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; HL60; HT_HG-U133A | 5.48e-06 | 200 | 109 | 8 | 2477_UP | |
| Drug | homoibotenic acid | 5.87e-06 | 8 | 109 | 3 | CID000194385 | |
| Drug | Imatinib | 5.87e-06 | 8 | 109 | 3 | DB00619 | |
| Drug | SU 5402 | 6.59e-06 | 55 | 109 | 5 | ctd:C105686 | |
| Drug | Ly294486 | 8.78e-06 | 9 | 109 | 3 | CID005311255 | |
| Drug | oriens | 9.45e-06 | 154 | 109 | 7 | CID000161645 | |
| Drug | quindine | 1.06e-05 | 219 | 109 | 8 | CID000001065 | |
| Drug | 3,7-diaminoheptan-2-one | 1.10e-05 | 61 | 109 | 5 | CID004477684 | |
| Drug | rubidium | 1.10e-05 | 61 | 109 | 5 | CID000105153 | |
| Drug | sorafenib | 1.12e-05 | 158 | 109 | 7 | CID000216239 | |
| Drug | AC1L9M5J | 1.14e-05 | 221 | 109 | 8 | CID000448615 | |
| Drug | amiodarone | 1.21e-05 | 160 | 109 | 7 | CID000002156 | |
| Drug | LY293558 | 1.24e-05 | 30 | 109 | 4 | CID000127894 | |
| Drug | A13108 | 1.25e-05 | 10 | 109 | 3 | CID000062278 | |
| Drug | Dasatinib | 1.25e-05 | 10 | 109 | 3 | DB01254 | |
| Drug | Y-S-H | 1.25e-05 | 10 | 109 | 3 | CID000449035 | |
| Drug | theaflavin | 1.25e-05 | 224 | 109 | 8 | CID000114777 | |
| Drug | 4-methylglutamic acid | 1.42e-05 | 31 | 109 | 4 | CID000005365 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 1.51e-05 | 302 | 109 | 9 | ctd:D003633 | |
| Drug | willardine | 1.61e-05 | 32 | 109 | 4 | CID000005123 | |
| Drug | Phenobarbital | 1.71e-05 | 11 | 109 | 3 | DB01174 | |
| Drug | J-ST | 1.71e-05 | 11 | 109 | 3 | CID005288655 | |
| Drug | YM872 | 1.71e-05 | 11 | 109 | 3 | CID000148200 | |
| Drug | sym 2206 | 1.71e-05 | 11 | 109 | 3 | CID005039877 | |
| Drug | L-Glutamic Acid | 1.88e-05 | 68 | 109 | 5 | DB00142 | |
| Drug | spermine | GRIA1 GRIA2 GRIK1 NAGS KCNJ2 KCNJ4 KCNJ10 KCNJ12 NPC1L1 SCN7A | 2.00e-05 | 394 | 109 | 10 | CID000001103 |
| Drug | lamotrigine | 2.03e-05 | 116 | 109 | 6 | CID000003878 | |
| Drug | oxindole | 2.06e-05 | 34 | 109 | 4 | CID000321710 | |
| Drug | riluzole | 2.09e-05 | 174 | 109 | 7 | CID000005070 | |
| Drug | dasatinib | 2.17e-05 | 70 | 109 | 5 | CID003062316 | |
| Drug | felbamate | 2.17e-05 | 70 | 109 | 5 | CID000003331 | |
| Drug | belinostat | B3GALNT1 ABL1 NTRK3 UNC93A GRIK1 SLCO1B1 SULT1C2 KCNJ2 FZD5 SLC9B2 HPX KDR SLC44A3 | 2.19e-05 | 678 | 109 | 13 | ctd:C487081 |
| Drug | Quisqualate | 2.27e-05 | 2 | 109 | 2 | DB02999 | |
| Drug | 2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C474829 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C561635 | |
| Drug | 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine | 2.27e-05 | 2 | 109 | 2 | ctd:C529910 | |
| Drug | Nilotinib | 2.27e-05 | 2 | 109 | 2 | DB04868 | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 2.27e-05 | 2 | 109 | 2 | ctd:C084273 | |
| Drug | 3-(4-dimethylamino-benzylidenyl)-2-indolinone | 2.27e-05 | 2 | 109 | 2 | ctd:C117011 | |
| Drug | 4-bromohomoibotenic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C023366 | |
| Drug | Atpa | 2.28e-05 | 12 | 109 | 3 | CID000002252 | |
| Drug | N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide | 2.28e-05 | 12 | 109 | 3 | ctd:C568507 | |
| Drug | PD 166285 | 2.28e-05 | 12 | 109 | 3 | CID005311382 | |
| Drug | C-X6 | 2.28e-05 | 12 | 109 | 3 | CID005288002 | |
| Drug | beta-tyrosine | 2.32e-05 | 35 | 109 | 4 | CID000440311 | |
| Drug | PhTX-343 | 2.60e-05 | 36 | 109 | 4 | CID000159548 | |
| Drug | C6H12NO5P | 2.60e-05 | 36 | 109 | 4 | CID000104962 | |
| Drug | clofilium | 2.84e-05 | 74 | 109 | 5 | CID000002798 | |
| Drug | mefenamic acid | 2.91e-05 | 37 | 109 | 4 | CID000004044 | |
| Drug | Fluoxetine | 3.10e-05 | 331 | 109 | 9 | ctd:D005473 | |
| Drug | L-BMAA | 3.24e-05 | 38 | 109 | 4 | CID000028558 | |
| Drug | CGS 19755 | 3.24e-05 | 38 | 109 | 4 | CID000068736 | |
| Drug | Tocopherols | 3.44e-05 | 77 | 109 | 5 | ctd:D024505 | |
| Drug | DETC-MeSO | 3.59e-05 | 39 | 109 | 4 | CID003035711 | |
| Drug | PD 173074 | 3.74e-05 | 14 | 109 | 3 | ctd:C115711 | |
| Drug | quinoxaline-2,3-dione | 3.74e-05 | 14 | 109 | 3 | CID011469229 | |
| Drug | aniracetam | 3.86e-05 | 130 | 109 | 6 | CID000002196 | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 4.05e-05 | 193 | 109 | 7 | 1715_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 4.19e-05 | 194 | 109 | 7 | 7494_UP | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 6101_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 5563_UP | |
| Disease | bone disease (implicated_via_orthology) | 4.48e-07 | 5 | 106 | 3 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.59e-06 | 156 | 106 | 7 | C0007131 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 3.01e-06 | 28 | 106 | 4 | DOID:0050866 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | ABL1 ROR1 GRIK2 SLCO1B1 STAT3 SLC5A5 UPK1B KDR FGFR1 KIT ALK | 3.09e-06 | 525 | 106 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ABL1 ROR1 GRIK2 SLCO1B1 STAT3 SLC5A5 UPK1B KDR FGFR1 KIT ALK | 3.09e-06 | 525 | 106 | 11 | C1257931 |
| Disease | Mammary Neoplasms | ABL1 ROR1 GRIK2 SLCO1B1 STAT3 SLC5A5 UPK1B KDR FGFR1 KIT ALK | 3.21e-06 | 527 | 106 | 11 | C1458155 |
| Disease | Breast Carcinoma | ABL1 ROR1 GRIK2 SLCO1B1 STAT3 SLC5A5 UPK1B KDR FGFR1 KIT ALK | 3.90e-06 | 538 | 106 | 11 | C0678222 |
| Disease | Large cell carcinoma of lung | 5.24e-06 | 32 | 106 | 4 | C0345958 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 9.68e-06 | 12 | 106 | 3 | EFO_0800544 | |
| Disease | Adenocarcinoma of lung (disorder) | 9.92e-06 | 206 | 106 | 7 | C0152013 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 1.28e-05 | 2 | 106 | 2 | C4016905 | |
| Disease | response to fluoropyrimidines | 1.28e-05 | 2 | 106 | 2 | EFO_0010825 | |
| Disease | HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC | 1.28e-05 | 2 | 106 | 2 | C4016109 | |
| Disease | Rotor Syndrome | 1.28e-05 | 2 | 106 | 2 | C0220991 | |
| Disease | Rotor syndrome | 1.28e-05 | 2 | 106 | 2 | cv:C0220991 | |
| Disease | lymphangioma (is_marker_for) | 1.28e-05 | 2 | 106 | 2 | DOID:1475 (is_marker_for) | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 1.28e-05 | 2 | 106 | 2 | 237450 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.74e-05 | 43 | 106 | 4 | DOID:9261 (is_marker_for) | |
| Disease | rectum adenocarcinoma (is_implicated_in) | 3.83e-05 | 3 | 106 | 2 | DOID:1996 (is_implicated_in) | |
| Disease | HEMANGIOMA, CAPILLARY INFANTILE | 3.83e-05 | 3 | 106 | 2 | 602089 | |
| Disease | HEMANGIOMA, CAPILLARY INFANTILE | 3.83e-05 | 3 | 106 | 2 | C1865871 | |
| Disease | Capillary infantile hemangioma | 3.83e-05 | 3 | 106 | 2 | cv:C1865871 | |
| Disease | TWIST1-related craniosynostosis | 7.63e-05 | 4 | 106 | 2 | cv:C4551902 | |
| Disease | Seminoma | 7.63e-05 | 4 | 106 | 2 | C0036631 | |
| Disease | Germ cell tumor of testis | 7.63e-05 | 4 | 106 | 2 | cv:C1336708 | |
| Disease | survival time, pneumonia, septic shock, Sepsis | 7.63e-05 | 4 | 106 | 2 | EFO_0000714, EFO_0003106, EFO_0006834, HP_0100806 | |
| Disease | Ki-1+ Anaplastic Large Cell Lymphoma | 7.63e-05 | 4 | 106 | 2 | C0206180 | |
| Disease | TESTICULAR GERM CELL TUMOR | 7.63e-05 | 4 | 106 | 2 | 273300 | |
| Disease | T-cell non-Hodgkin lymphoma (is_implicated_in) | 7.63e-05 | 4 | 106 | 2 | DOID:0081312 (is_implicated_in) | |
| Disease | Malignant tumor of testis | 7.63e-05 | 4 | 106 | 2 | cv:C0153594 | |
| Disease | colorectal cancer (is_implicated_in) | 7.77e-05 | 121 | 106 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Schizophrenia | PDGFRB NTRK3 GRIA1 GRIA2 GRIK1 GRIK2 SYNGR1 HRH1 SYP KDR FGFR1 ALK | 8.01e-05 | 883 | 106 | 12 | C0036341 |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 1.27e-04 | 5 | 106 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | neuroblastoma (implicated_via_orthology) | 1.27e-04 | 5 | 106 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | 1-linolenoyl-GPE (18:3) measurement | 1.27e-04 | 5 | 106 | 2 | EFO_0800365 | |
| Disease | stomach cancer (is_implicated_in) | 1.34e-04 | 72 | 106 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Schizoaffective Disorder | 1.54e-04 | 29 | 106 | 3 | C0036337 | |
| Disease | Disproportionate short stature | 1.74e-04 | 77 | 106 | 4 | C0878659 | |
| Disease | Psychosexual Disorders | 1.90e-04 | 6 | 106 | 2 | C0033953 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 1.90e-04 | 6 | 106 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | Hypoactive Sexual Desire Disorder | 1.90e-04 | 6 | 106 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 1.90e-04 | 6 | 106 | 2 | C0036902 | |
| Disease | Frigidity | 1.90e-04 | 6 | 106 | 2 | C0016722 | |
| Disease | Orgasmic Disorder | 1.90e-04 | 6 | 106 | 2 | C0029261 | |
| Disease | Intellectual Disability | 2.15e-04 | 447 | 106 | 8 | C3714756 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.43e-04 | 84 | 106 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | 1-arachidonoyl-GPI (20:4) measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0800256 | |
| Disease | 1-linoleoyl-GPI (18:2) measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0800266 | |
| Disease | Craniosynostosis syndrome | 2.65e-04 | 7 | 106 | 2 | cv:C0010278 | |
| Disease | 1-eicosatrienoylglycerophosphocholine measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0021081 | |
| Disease | peripheral neuropathy | 2.65e-04 | 7 | 106 | 2 | EFO_0003100 | |
| Disease | 1-eicosapentaenoyl-GPE (20:5) measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0800353 | |
| Disease | Glioma | 2.78e-04 | 87 | 106 | 4 | C0017638 | |
| Disease | Bipolar Disorder | 3.33e-04 | 477 | 106 | 8 | C0005586 | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0800260 | |
| Disease | 1-linoleoyl-GPE (18:2) measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0800247 | |
| Disease | deoxycholic acid glucuronide measurement | 3.53e-04 | 8 | 106 | 2 | EFO_0800575 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.69e-04 | 169 | 106 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Parkinson disease, disease progression measurement | 3.75e-04 | 39 | 106 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | Adenocarcinoma of large intestine | 4.05e-04 | 96 | 106 | 4 | C1319315 | |
| Disease | Leukemia, Myelocytic, Acute | 4.11e-04 | 173 | 106 | 5 | C0023467 | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 4.53e-04 | 9 | 106 | 2 | EFO_0800248 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.53e-04 | 9 | 106 | 2 | EFO_0800562 | |
| Disease | X-21467 measurement | 4.53e-04 | 9 | 106 | 2 | EFO_0020007 | |
| Disease | Malignant neoplasm of breast | ABL1 ROR1 GRIK2 SLCO1B1 STAT3 SLC5A5 UPK1B SLC35A2 KDR FGFR1 KIT ALK | 4.82e-04 | 1074 | 106 | 12 | C0006142 |
| Disease | Malignant Head and Neck Neoplasm | 5.36e-04 | 44 | 106 | 3 | C0278996 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.36e-04 | 44 | 106 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 5.73e-04 | 45 | 106 | 3 | C0278701 | |
| Disease | Depressive disorder | 6.30e-04 | 289 | 106 | 6 | C0011581 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 6.88e-04 | 11 | 106 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | atopic asthma | 7.75e-04 | 199 | 106 | 5 | EFO_0010638 | |
| Disease | diabetic maculopathy | 8.24e-04 | 12 | 106 | 2 | EFO_0010133 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 8.24e-04 | 12 | 106 | 2 | DOID:3963 (is_marker_for) | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 9.72e-04 | 13 | 106 | 2 | EFO_0800547 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 9.72e-04 | 13 | 106 | 2 | EFO_0800474 | |
| Disease | prostate carcinoma (is_implicated_in) | 9.72e-04 | 13 | 106 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 9.78e-04 | 54 | 106 | 3 | C0149925 | |
| Disease | ecosanoids measurement | 1.03e-03 | 55 | 106 | 3 | EFO_0020044 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.09e-03 | 125 | 106 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.09e-03 | 125 | 106 | 4 | C1879321 | |
| Disease | Testicular Germ Cell Tumor | 1.13e-03 | 14 | 106 | 2 | C1336708 | |
| Disease | Seizures | 1.16e-03 | 218 | 106 | 5 | C0036572 | |
| Disease | Malignant Neoplasms | 1.19e-03 | 128 | 106 | 4 | C0006826 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.19e-03 | 128 | 106 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.20e-03 | 58 | 106 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.20e-03 | 58 | 106 | 3 | C0038587 | |
| Disease | colon cancer (is_marker_for) | 1.27e-03 | 59 | 106 | 3 | DOID:219 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.30e-03 | 15 | 106 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.30e-03 | 15 | 106 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.30e-03 | 15 | 106 | 2 | C0154091 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 1.30e-03 | 15 | 106 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Rhabdomyosarcoma | 1.30e-03 | 15 | 106 | 2 | C0035412 | |
| Disease | Lobar Holoprosencephaly | 1.48e-03 | 16 | 106 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 1.48e-03 | 16 | 106 | 2 | C0751617 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.48e-03 | 16 | 106 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | gliosarcoma | 1.48e-03 | 16 | 106 | 2 | C0206726 | |
| Disease | carcinoma (implicated_via_orthology) | 1.60e-03 | 64 | 106 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Brachycephaly | 1.68e-03 | 17 | 106 | 2 | C0221356 | |
| Disease | eicosapentaenoate EPA; 20:5n3 measurement | 1.68e-03 | 17 | 106 | 2 | EFO_0021049 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVVFSFLWLVGSSAW | 121 | Q8TBG9 | |
| VFGFLNFILWAGNIW | 181 | Q8TBG9 | |
| YVESIICVFIGFGWW | 511 | O00400 | |
| FYDFLRGLEASWIWV | 401 | Q96LX7 | |
| FWAEFWKFSGIVFSR | 61 | Q86V21 | |
| TFLLGLTWGFAFFAW | 2946 | Q8IZF6 | |
| IWTTFWATPGFFNKF | 281 | Q6ZNB7 | |
| LSTRIVGGIWWFFTL | 646 | P39086 | |
| VGGIWWFFTLIIISS | 651 | P39086 | |
| WWALGVCLFEFLTGI | 761 | Q96GX5 | |
| DVWSFGILLWEIFTL | 671 | P22455 | |
| WLFWFLALTVGGAYI | 721 | Q96F81 | |
| IWGSIALWVVFFGIY | 1011 | Q9Y2Q0 | |
| VSETTFDVFVWFGWA | 336 | P21918 | |
| ADKWGFGATVWEVFS | 706 | P52333 | |
| AFVLSWLFFGCVFWL | 91 | P63252 | |
| FLVSWLFFGLLFWCI | 66 | P48050 | |
| WGWVIVFVSFLTQFL | 11 | Q7RTY1 | |
| DVWSFGVLLWEVFSY | 406 | P42679 | |
| FLASWLLFGIIFWVI | 91 | Q14500 | |
| AGTWFLFGVVWYLVA | 76 | P78508 | |
| DVWSYGIFLWELFSL | 851 | P10721 | |
| SFWRIFLLGSVWLDY | 11 | Q16288 | |
| SDVWSFGVILWEIFT | 751 | Q16288 | |
| WAFGVTLWETFTFCQ | 771 | Q16832 | |
| WFWILLGLAYFASVL | 236 | Q9NYG8 | |
| SWWGYEVLTFFLLGQ | 106 | O75752 | |
| SWSFGVLLWEIFSLG | 706 | P29376 | |
| SLSGRIVGGVWWFFT | 616 | P42262 | |
| IVGGVWWFFTLIIIS | 621 | P42262 | |
| ELSLWVIQGCFWLFG | 336 | Q2PZI1 | |
| SGFSSIPDAFWWAVV | 426 | P22001 | |
| WFWILVGLAYFAAVL | 301 | P57789 | |
| GSFSNKQWIFFWFGL | 491 | Q8N159 | |
| IFWGRGLFSATSWGL | 266 | Q86VF5 | |
| LTCFAGFWLIWGLIV | 11 | Q8TB68 | |
| FLWFAVGLWLLAAFS | 86 | Q86SM5 | |
| CGLLVLASWFIIFWF | 141 | Q8NG98 | |
| LLGQFFQGWGTWVAS | 336 | Q9UHC9 | |
| FLWAAWVFSLVLGLG | 26 | P26012 | |
| ERTFATFWIGLWSVL | 231 | Q13467 | |
| FTVFWIGLWSVLCFV | 276 | Q9H461 | |
| WFIFSLIWSVGATGD | 2106 | Q9P2D7 | |
| WGWTCTFLGGFVLLV | 96 | A5D6W6 | |
| SDVWSFGVLLWEIFT | 681 | P11362 | |
| SDVWSFGILLWETFS | 741 | P16591 | |
| FESWFLFIHFGGWAE | 391 | Q00597 | |
| FSIKSDVWAFGVLLW | 416 | P00519 | |
| DLGCLSFGFSWFWFR | 241 | P27544 | |
| AWLTLWVFGTSFLPF | 146 | O60427 | |
| YSTGTGWIWLAVVFV | 16 | Q6PEY0 | |
| VGYLTQAEWWELLFF | 491 | Q8IWT3 | |
| DTAWLFLFFLFWTGL | 31 | Q8N4M1 | |
| QWFLGFAVFLLPWAS | 131 | Q8NBI2 | |
| ATILGAWFLSFLWVI | 146 | P35367 | |
| DVWSFGVLLWEIFTL | 676 | P22607 | |
| GGVWWFFTLIIISSY | 616 | P42261 | |
| LSTRIVGGIWWFFTL | 631 | Q13002 | |
| VGGIWWFFTLIIISS | 636 | Q13002 | |
| AFWVGETVFLLWNSL | 51 | Q14CX5 | |
| VWSFGILLWEIFTLG | 886 | P09619 | |
| VIVSWVFGFLSEIWP | 141 | Q8NGT5 | |
| GGWGWAVAVSFFFVE | 21 | O15403 | |
| SDVWSFGILLWETFS | 741 | P07332 | |
| TIFGSWFWVIDAASV | 516 | Q5JY77 | |
| AEGVLFFQGDREWFW | 156 | P02790 | |
| FFQGDREWFWDLATG | 161 | P02790 | |
| VGNLWFVFKETGWAA | 216 | P08247 | |
| TFFWLVAAAAWGKGL | 161 | Q5VXT5 | |
| FLASWLLFGVIFWVI | 91 | B7U540 | |
| AFVWWLLGIGALTFA | 156 | Q969S0 | |
| IAAGVLFFTGWWIII | 26 | O95807 | |
| IGTVLSEFLWLWGCF | 406 | Q8WV83 | |
| FWEFINSTEGSFLWI | 21 | Q4G0N0 | |
| WLVVVTGWTLFVGVY | 151 | P03923 | |
| VGVLVFTQFWFWFPL | 761 | Q99460 | |
| WQWGFILGFVLGAVS | 231 | Q86UD5 | |
| FFENIGSILWWAVLG | 151 | Q6AI14 | |
| SLISGLILIFEWWYF | 71 | Q9NRC1 | |
| LVSWVFGFLFQIWPV | 146 | Q8NGU2 | |
| GAWWLNFLVSGLFSI | 256 | Q9Y6L6 | |
| WWAEGTAVATRGFFF | 251 | P78381 | |
| DTWSFGVLLWEIFSL | 1311 | Q9UM73 | |
| WGSLLFYVVFSLLWG | 1036 | P98196 | |
| WSFGVVLWEIFSFGL | 676 | Q01973 | |
| WFSSGAFIRADLGEW | 531 | Q8N2E2 | |
| YLFLLLWEDTQGWGF | 6 | P98066 | |
| GWGWVVVLSAFFQSA | 11 | Q7RTY0 | |
| VFGWGLPAVFVAVWV | 326 | Q03431 | |
| RYTFWTFVVGGTLVW | 241 | Q92911 | |
| GKGFSFWVWLDNIID | 556 | P40763 | |
| ILLGRGFTFWQWFDG | 506 | P42226 | |
| GFTFWQWFDGVLDLT | 511 | P42226 | |
| LGIAQVFSFLFSWWN | 11 | Q9HCF6 | |
| FGKNDVWFWVIFSAI | 621 | Q9NXL6 | |
| ETFINGKVVWGSWFD | 161 | O00338 | |
| GAWWLGFLVSGLFSI | 256 | Q9NPD5 | |
| DVWSFGVLLWEIFSL | 1096 | P35916 | |
| FVFSGLWGVADAVWQ | 351 | Q86WB7 | |
| ASVVAGILFFTGWWI | 26 | P56557 | |
| QRWWFGLTLFFVVLG | 141 | Q5GH76 | |
| LSDIGVSAFWAFLWF | 106 | O43759 | |
| VDISFGWSLALGWIS | 181 | B3SHH9 | |
| RVFGYWWGTSFLLIN | 11 | Q8TCU3 | |
| WQWAFLLGFVLGAVS | 211 | Q4ZJI4 | |
| GDLLFSALWTFLWFV | 106 | A8MWL6 | |
| SALWTFLWFVGFCFL | 111 | A8MWL6 | |
| IGDLLFSALWTFLWF | 106 | O43760 | |
| LLDLGFSGLWSFLWF | 106 | O43761 | |
| FFWVGGAAVLAVGIW | 26 | A1L157 | |
| WWNVFVPFFAADGLS | 46 | Q969S6 | |
| FGFAILCWTFWVLLG | 236 | O75841 | |
| YWVDFTFSFSGGVTW | 281 | Q7Z5H4 | |
| LGDPWNWLDFSVTVF | 176 | Q01118 | |
| EVGTIFALSWLITWF | 211 | Q96BZ9 | |
| SDVWSFGVLLWEIFS | 1086 | P35968 | |
| LFWLAGSAVIAFGLW | 21 | O60636 | |
| VFTILTGLGWLFSSW | 126 | A6NGA9 | |
| GTFFFIIGLWWCTKS | 11 | Q9NWC5 | |
| TTSIGWRFQLWFLGL | 11 | Q2WGJ8 |